[{"text": "PREMIUM Caribou Biosciences Starts Phase 1 Trial for Lupus Drug Candidate MT Newswires Mon, Jan 13, 2025, 12:47 PM 1 min read In This Article: CRBU -4.20% Caribou Biosciences (CRBU) said Sunday it initiated the phase 1 trial evaluating its experimental th PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CRBU", "date": "2025-01-13T09:47:34+00:00", "sentiment": {"score": 0.062309267930686474, "confidence": 0.0734674483537674, "probabilities": {"positive": 0.0734674483537674, "negative": 0.011158180423080921, "neutral": 0.9153743982315063}}, "embedding": [-0.0965404286980629, -0.10241133719682693, 0.03598817437887192, 0.07195556908845901, 0.1855577975511551, 0.01444229669868946, -0.2004244178533554, 0.24318291246891022, -0.11941859126091003, -0.014151941053569317, -0.02490994706749916, -0.019140668213367462, 0.05964621156454086, -0.04334710165858269, -0.018070198595523834, -0.016711696982383728, 0.04195067659020424, -0.19829855859279633, 0.2358008176088333, 0.04859018698334694, -0.1822015345096588, -0.053461700677871704, -0.05131583660840988, 0.08000738173723221, 0.04735184833407402, 0.028314931318163872, -0.21873795986175537, -0.003994326572865248, 0.04278818517923355, 0.006494493689388037, 0.17468209564685822, 0.06302650272846222, 0.03524195775389671, -0.0013012995477765799, 0.05099748820066452, -0.07504503428936005, -0.03657567873597145, -0.08975513279438019, -0.16401530802249908, 0.06875549256801605, 0.1290644258260727, -0.11695645749568939, -0.11621309071779251, 0.017746182158589363, 0.048047568649053574, -0.08789650350809097, -0.10167685151100159, 0.1679334044456482, 0.017907602712512016, 0.002095120958983898, -0.05725563317537308, -0.28500914573669434, 0.009234638884663582, 0.11245793104171753, 0.015673907473683357, 0.05293382331728935, -0.13647666573524475, -0.05026097595691681, 0.1448974311351776, 0.0030836095102131367, -0.08266758173704147, -0.004670357331633568, -0.04447658360004425, -0.04886309802532196, 0.025339584797620773, -0.05519314110279083, -0.09725716710090637, -0.0456993393599987, 0.13710860908031464, -0.02578742615878582, -0.05245157331228256, 0.0394439771771431, 0.09890759736299515, -0.011684516444802284, 0.04642830789089203, 0.24898797273635864, -0.07260753214359283, -0.07703645527362823, 0.11494290828704834, -0.040660277009010315, -0.0772440955042839, -0.1363312304019928, 0.12556092441082, -0.1436549425125122, 0.07772543281316757, -0.020975444465875626, 0.04732673615217209, -0.11031728982925415, -0.1853380799293518, -0.10018624365329742, 0.22589555382728577, -0.04743068665266037, 0.044829435646533966, 0.005878748372197151, -0.22481611371040344, 0.049205318093299866, -0.1059567853808403, -0.1222844198346138, -0.002349691931158304, 0.02523031085729599, -0.10125875473022461, -0.07920829206705093, 0.05982786417007446, -0.14523431658744812, -0.13360969722270966, -0.14693066477775574, 0.027041783556342125, 0.0468558594584465, -0.09096803516149521, 0.05955976992845535, 0.06188808009028435, 0.13848990201950073, 0.13416370749473572, -0.05664236098527908, -0.04851939156651497, 0.20675845444202423, -0.20484822988510132, 0.041248951107263565, 0.15189222991466522, 0.049751751124858856, 0.1268751472234726, -0.058860957622528076, -0.028554031625390053, -0.26607006788253784, 0.08780395984649658, -0.016261417418718338, -0.10464481264352798, 1.5266818104644894e-32, 0.05139491334557533, 0.056605760008096695, -0.01081167720258236, -0.06520038098096848, -0.08184393495321274, 0.009579512290656567, -0.1273626983165741, 0.04454699531197548, -0.060850590467453, -0.1725388765335083, -0.10577408969402313, 0.14772148430347443, 0.03657759726047516, 0.2432277351617813, -0.21070048213005066, -0.05321564897894859, -0.17923371493816376, -0.01180644053965807, 0.06112676486372948, 0.03560880199074745, 0.09765274077653885, -0.19863587617874146, -0.0006771456100977957, -0.0008969628834165633, -0.006244610995054245, 0.07422216236591339, 0.04943806678056717, -0.06857585161924362, 0.1096736341714859, 0.16249141097068787, -0.17684400081634521, 0.09065495431423187, -0.061199214309453964, 0.027657629922032356, 0.022696180269122124, 0.049337368458509445, 0.005651063751429319, -0.12872205674648285, -0.11151106655597687, 0.04294933006167412, 0.1597159206867218, -0.0003057698195334524, -0.12962676584720612, -0.21210786700248718, 0.2505236268043518, 0.03873933479189873, -0.03714580833911896, -0.08287850767374039, 0.06259012967348099, -0.049504730850458145, 0.05539664626121521, -0.02968430146574974, -0.08839448541402817, 0.008780725300312042, 0.06330527365207672, 0.14331118762493134, -0.09063149988651276, -0.16064581274986267, 0.04868558049201965, 0.007386337500065565, 0.1423664689064026, 0.11796645075082779, 0.1161448210477829, -0.16516058146953583, -0.04337921738624573, 0.03283587470650673, -0.20413586497306824, -0.2647789716720581, -0.09314368665218353, 0.05914795771241188, 0.08805172890424728, -0.16080647706985474, 0.17642751336097717, 0.027423158288002014, -0.013114855624735355, -0.0019098108168691397, 0.2276219129562378, 0.21283173561096191, -0.06161866337060928, 0.05668565258383751, 0.03882928937673569, 0.01405639573931694, 0.017873026430606842, 0.10878351330757141, 0.11899887770414352, -0.08582285046577454, -0.023142896592617035, -0.10442463308572769, -0.17476463317871094, 0.0015073716640472412, 0.10607302188873291, 0.025869084522128105, 0.011472557671368122, 0.1462750881910324, -0.09620567411184311, -1.345260420462393e-32, -0.06338859349489212, -0.08041289448738098, 0.11875738203525543, 0.08140074461698532, 0.029148032888770103, 0.11355995386838913, 0.09613802284002304, -0.041364554315805435, 0.3540727198123932, 0.14118961989879608, 0.05544215440750122, 0.059599027037620544, -0.09399295598268509, -0.054200608283281326, 0.1597919464111328, 0.10586457699537277, 0.04983324930071831, -0.09822310507297516, -0.15245230495929718, 0.08773013949394226, -0.010003472678363323, 0.12352767586708069, 0.030622748658061028, 0.16341382265090942, 0.2243712693452835, -0.07518821954727173, 0.1372680813074112, 0.05931272730231285, 0.07293160259723663, -0.07252976298332214, -0.22298365831375122, 0.014072676189243793, -0.17533542215824127, 0.006201090291142464, -0.14848202466964722, 0.07118400931358337, 0.11098372936248779, -0.056359775364398956, 0.04140358790755272, 0.07752393931150436, 0.12909893691539764, -0.11485935747623444, -0.23077179491519928, -0.06084543839097023, 0.08234277367591858, -0.01810281351208687, 0.044999416917562485, 0.001331938779912889, 0.12719018757343292, 0.011436017230153084, 0.07345766574144363, 0.018750816583633423, 0.032847169786691666, -0.01271669752895832, -0.01828356832265854, -0.09686854481697083, 0.09696614742279053, 0.06859492510557175, -0.10363772511482239, 0.16551291942596436, 0.08317280560731888, 0.1802317500114441, -0.1617012619972229, -0.06904254853725433, 0.10083574801683426, 0.03758304566144943, 0.21120892465114594, -0.07627467066049576, 0.1173061802983284, -0.07936156541109085, 0.002879520645365119, 0.10409488528966904, 0.03754652664065361, -0.10932937264442444, 0.03696844354271889, 0.22723565995693207, -0.2358175814151764, -0.007654697168618441, -0.2417127788066864, -0.10652557015419006, 0.012576908804476261, -0.14897041022777557, -0.0017426188569515944, 0.058588653802871704, 0.06661172956228256, -0.03847862407565117, -0.11069197207689285, -0.017966503277420998, 0.007687661796808243, 0.15506543219089508, -0.10897340625524521, -0.02877349592745304, -0.06771810352802277, 0.19166094064712524, 0.17127177119255066, -9.945685519596736e-08, 0.23477770388126373, -0.12331954389810562, 0.1356014609336853, -0.043544795364141464, 0.08697136491537094, 0.09387864917516708, -0.06105942651629448, -0.048291295766830444, -0.08301747590303421, 0.11036211252212524, -0.11794090270996094, 0.05692704766988754, 0.05560789629817009, 0.07302764058113098, 0.044378865510225296, 0.16984932124614716, 0.03555826470255852, 0.008586855605244637, -0.12679988145828247, 0.08927322924137115, -0.03444735333323479, 0.06965652853250504, 0.0755247175693512, -0.09249920397996902, -0.020734261721372604, -0.23325715959072113, 0.1467522829771042, 0.060931507498025894, -0.05991418659687042, -0.10204069316387177, -0.032087069004774094, 0.11636010557413101, -0.07752037048339844, -0.057274121791124344, -0.07682033628225327, 0.024856768548488617, 0.09268558770418167, 0.09141704440116882, -0.06507305800914764, 0.0744091123342514, 0.1024157777428627, 0.12010303884744644, 0.003475907491520047, -0.053080443292856216, -0.16390222311019897, 0.03844982013106346, -0.12687058746814728, 0.020029287785291672, 0.0764114111661911, -0.13712100684642792, -0.03497389703989029, 0.06430967897176743, -0.1317271590232849, -0.03807266801595688, -0.06092352047562599, 0.20708061754703522, -0.02625155821442604, -0.26510298252105713, -0.015367284417152405, -0.12284628301858902, 0.07894370704889297, -0.13635402917861938, 0.12292440235614777, 0.017006894573569298], "changes": {"1wk": -1.2903213897927004}}, {"text": "Caribou Biosciences Initiates the CB-010 GALLOP Phase 1 Trial in Lupus and Provides Outlook for Multiple Clinical Datasets in 2025 Caribou Biosciences, Inc. Mon, Jan 13, 2025, 3:05 AM 11 min read In This Article: CRBU -4.20% Caribou Biosciences, Inc. -- CB-010 GALLOP Phase 1 trial initiated in lupus -- -- CB-012 AMpLify Phase 1 trial in r/r AML completes dose level 3 with no DLTs; enrolling patients at dose level 4 -- -- CB-010 ANTLER 2L LBCL and CB-011 CaMMouflage r/r MM Phase 1 clinical data expected in H1 2025 -- -- Sri Ryali appointed chief financial officer -- -- Caribou to present at 43 r d Annual J.P. Morgan Healthcare Conference on Thursday, January 16, at 10:30 am PST -- BERKELEY, Calif., Jan. 12, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced initiation of the GALLOP Phase 1 clinical trial evaluating CB-010 in patients with lupus nephritis (LN) and extrarenal lupus (ERL). In addition, Caribou highlighted successful execution across its three clinical-stage allogeneic CAR-T cell therapy programs in hematologic malignancies over the past year and provided an outlook on multiple clinical data catalysts planned for 2025. \u201cWe are excited to share we have initiated the GALLOP Phase 1 trial. This milestone is a testament to the significant momentum we achieved across all four clinical programs throughout 2024,\u201d said Rachel Haurwitz, PhD, Caribou\u2019s president and chief executive officer. \u201cIn the first half of 2025, we plan to report clinical data from our lead program, CB-010, in second-line and CD19 relapsed large B cell lymphoma patients as well as dose escalation data from our second program, CB-011, in relapsed or refractory multiple myeloma. Pending confirmation of our HLA matching strategy, we plan to initiate a pivotal Phase 3 trial for CB-010 in second-line large B cell lymphoma in the second half of 2025. We are excited to be on the forefront of a new era for allogeneic CAR-T cell therapies, which offer broad access and rapid availability to patients and healthcare systems.\u201d 2024 clinical highlights and corporate accomplishments Clinical highlights CB-010, a clinical-stage allogeneic anti-CD19 CAR-T cell therapy for B cell non-Hodgkin lymphoma At the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, Caribou presented clinical data from the ongoing ANTLER Phase 1 clinical trial that indicated a single dose of CB-010 has the potential to be on par with the safety, efficacy, and durability of approved autologous CAR-T cell therapies. A retrospective analysis of all patient data demonstrated that patients who received a dose of CB-010 manufactured from a donor with \u22654 matching human leukocyte antigen (HLA) alleles showed improved progression free survival (PFS). To confirm the HLA matching strategy, Caribou is enrolling approximately 20 additional second-line large B cell lymphoma (2L LBCL) patients in the ongoing ANTLER Phase 1 clinical trial. Caribou also began enrolling a proof-of-concept cohort of up to 10 patients who have relapsed following any prior CD19-targeted therapy in this population of unmet need. Caribou plans to present data from both the additional 2L and prior CD19 relapsed LBCL patient cohorts in H1 2025. The company plans to initiate a pivotal Phase 3 trial of CB-010 in the second half of 2025, should data from the additional 2L LBCL patients confirm the initial observation that partial HLA matching of patient to the donor results in outcomes on par with autologous CAR-T cell therapies. The Phase 3 trial would be initiated after agreement with the FDA on a pivotal trial design. Story Continues CB-010, a clinical-stage allogeneic anti-CD19 CAR-T cell therapy for lupus Caribou expanded the CB-010 program following clearance of its Investigational New Drug (IND) application by the U.S. Food and Drug Administration (FDA) for CB-010 in LN and ERL. The FDA granted Fast Track designation to CB-010 for refractory systemic lupus erythematosus (SLE). Caribou has initiated the GALLOP Phase 1 clinical trial , an open-label, multicenter clinical trial designed to evaluate a single infusion of CB-010 in adult patients with LN and ERL. CB-011, a clinical-stage allogeneic anti-BCMA CAR-T cell therapy for multiple myeloma In the dose escalation portion of the CaMMouflage Phase 1 clinical trial for relapsed or refractory multiple myeloma (r/r MM), Caribou implemented a lymphodepletion regimen that includes a deeper dose of cyclophosphamide (increased from 300 to 500 mg/m 2 /day together with the same fludarabine dose of 30 mg/m 2 /day for 3 days). Following observations of efficacy, Caribou is enrolling additional patients as backfill at active dose levels with the deeper lymphodepletion regimen. No DLTs have been observed in CaMMouflage. Caribou plans to present dose escalation data on a minimum of 15 patients at active doses from the ongoing CaMMouflage Phase 1 clinical trial in H1 2025. CB-012, a clinical-stage allogeneic anti-CLL-1 CAR-T cell therapy for acute myeloid leukemia The FDA granted Fast Track and Orphan Drug designations to CB-012 for relapsed or refractory acute myeloid leukemia (r/r AML). Caribou is enrolling patients with r/r AML in the dose escalation portion of the ongoing AMpLify Phase 1 clinical trial . Enrollment has concluded for dose level 3 (150x10 6 CAR-T cells, N=3) and no DLTs were observed. Patients are being enrolled at dose level 4 (300x10 6 CAR-T cells). Corporate updates Appointed experienced executive leaders and expanded the scientific advisory board (SAB) In January 2024, Tim Kelly was appointed chief technology officer and he leads Caribou\u2019s process development and manufacturing organizations. In August 2024, Tina Albertson, MD, PhD , was appointed chief medical officer and she leads Caribou\u2019s clinical programs and the clinical, regulatory, and medical affairs functions. In January 2025, Sri Ryali was appointed chief financial officer and he leads Caribou\u2019s corporate finance, investor relations, and corporate communications functions. Terri Laufer, MD , was appointed to Caribou\u2019s SAB. She is a leading rheumatologist known for her extensive research into immune cell regulation and dysfunction that leads to autoimmune diseases. $281M in cash, cash runway into H2 2026 Caribou previously reported $281 million in cash, cash equivalents, and marketable securities as of September 30, 2024, which is expected to fund the current operating plan into H2 2026. 2025 Anticipated milestones CB-010 ANTLER: Caribou plans to present data from both the additional 2L and prior CD19 relapsed LBCL patient cohorts in H1 2025. Caribou plans to initiate a pivotal Phase 3 clinical trial in H2 2025 should data confirm the initial observation that partial HLA matching drives outcomes that are on par with autologous CAR-T cell therapies. CB-010 GALLOP: Caribou plans to provide updates as the GALLOP Phase 1 clinical trial in LN and ERL advances. CB-011 CaMMouflage: Caribou plans to present dose escalation data from the ongoing CaMMouflage Phase 1 clinical trial in r/r MM in H1 2025. CB-012 AMpLify: Caribou plans to provide updates on dose escalation as the AMpLify Phase 1 clinical trial in r/r AML advances. Caribou to present at the 43rd Annual J.P. Morgan Healthcare Conference Dr. Haurwitz is scheduled to present a corporate update at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 10:30 am PST. A live webcast of the presentation will be accessible via Caribou\u2019s website on the Events page. The archived webcast will be available on the Caribou website for 30 days after the event. About CB-010 CB-010 is the lead clinical-stage product candidate from Caribou\u2019s allogeneic CAR-T cell therapy platform, and it is being evaluated in patients with relapsed or refractory B cell non-Hodgkin lymphoma (r/r B-NHL) in the ongoing ANTLER Phase 1 clinical trial and in patients with lupus nephritis (LN) and extrarenal lupus (ERL) in the GALLOP Phase 1 clinical trial. To Caribou\u2019s knowledge, CB-010 is the first allogeneic CAR-T cell therapy in the clinic with a PD-1 knockout, a genome-editing strategy designed to improve CAR-T cell activity by limiting premature CAR-T cell exhaustion. The FDA granted CB-010 Regenerative Medicine Advanced Therapy (RMAT) and Orphan Drug designations for B-NHL and Fast Track designations for both B-NHL and refractory systemic lupus erythematosus (SLE). Additional information on the ANTLER trial ( NCT04637763 ) and GALLOP trial ( NCT06752876 ) can be found at clinicaltrials.gov . About CB-011 CB-011 is a product candidate from Caribou\u2019s allogeneic CAR-T cell therapy platform and is being evaluated in patients with relapsed or refractory multiple myeloma (r/r MM) in the CaMMouflage Phase 1 trial. CB-011 is an allogeneic anti-BCMA CAR-T cell therapy engineered using Cas12a chRDNA genome-editing technology. To Caribou\u2019s knowledge, CB-011 is the first allogeneic CAR-T cell therapy in the clinic that is engineered to improve antitumor activity through an immune cloaking strategy with a B2M knockout and insertion of a B2M\u2013HLA-E fusion protein to blunt immune-mediated rejection. CB-011 has been granted Fast Track and Orphan Drug designations by the FDA. Additional information on the CaMMouflage trial ( NCT05722418 ) can be found at clinicaltrials.gov . About CB-012 CB-012 is a product candidate from Caribou\u2019s allogeneic CAR-T cell therapy platform and is being evaluated in the AMpLify Phase 1 clinical trial in patients with relapsed or refractory acute myeloid leukemia (r/r AML). CB-012 is an anti-CLL-1 CAR-T cell therapy engineered with five genome edits, enabled by Caribou\u2019s patented next-generation CRISPR technology platform, which uses Cas12a chRDNA genome editing to significantly improve the specificity of genome edits. To Caribou\u2019s knowledge, CB-012 is the first allogeneic CAR-T cell therapy with both checkpoint disruption, through a PD-1 knockout, and immune cloaking, through a B2M knockout and B2M\u2013HLA-E fusion protein insertion; both armoring strategies are designed to improve antitumor activity. Caribou has exclusively in-licensed from Memorial Sloan Kettering Cancer Center (MSKCC) in the field of allogeneic CLL-1-targeted cell therapy a panel of fully human scFvs targeting CLL-1, from which the company has selected a scFv for the generation of the company\u2019s CAR. CB-012 was granted Fast Track and Orphan Drug designations by the FDA.\u00a0Additional information on the AMpLify trial ( NCT06128044 ) can be found at clinicaltrials.gov . About Caribou Biosciences, Inc. Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company\u2019s genome-editing platform, including its Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve activity against disease. Caribou is advancing a pipeline of off-the-shelf cell therapies from its CAR-T platform to offer broad access and rapid availability of treatments for patients with hematologic malignancies and autoimmune diseases.\u00a0Follow us @CaribouBio and visit www.cariboubio.com . Forward-looking statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terms such as \u201cmay,\u201d \u201cwill,\u201d \u201cshould,\u201d \u201cexpect,\u201d \u201cplan,\u201d \u201canticipate,\u201d \u201ccould,\u201d \u201cintend,\u201d \u201ctarget,\u201d \u201cproject,\u201d \u201ccontemplate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cpredict,\u201d \u201cpotential,\u201d or \u201ccontinue,\u201d or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. These forward-looking statements include, without limitation, statements related to Caribou\u2019s strategy, plans, and objectives, and expectations regarding its clinical and preclinical development programs, including its expectations regarding plans to present or provide (i) ANTLER Phase 1 clinical trial data in H1 2025 from both the additional 2L and prior CD19 relapsed LBCL patient cohorts and timing and commencement of an ANTLER pivotal Phase 3 clinical trial; (ii) dose escalation data in H1 2025 from the ongoing CaMMouflage Phase 1 clinical trial for CB-011 in r/r MM; (iii) updates from dose escalation from the AMpLify Phase 1 clinical trial for CB-012; and (iv) updates from the GALLOP Phase 1 clinical trial for CB-010 in patients with LN and ERL; as well as its expected funding runway of cash, cash equivalents, and marketable securities. Management believes that these forward-looking statements are reasonable as and when made. However, such forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include, without limitation, risks inherent in the development of cell therapy products; uncertainties related to the initiation, cost, timing, progress, and results of its current and future research and development programs, preclinical studies, and clinical trials; the risk that initial, preliminary, or interim clinical trial data will not ultimately be predictive of the safety and efficacy of Caribou\u2019s product candidates or that clinical outcomes may differ as patient enrollment continues and as more patient data becomes available; the risk that preclinical study results observed will not be borne out in human patients or different conclusions or considerations are reached once additional data have been received and fully evaluated; the ability to obtain key regulatory input and approvals; and risks related to its limited operating history, history of net operating losses, financial position, and its ability to raise additional capital as needed to fund its operations and product candidate development as well as other risk factors described from time to time in Caribou\u2019s filings with the Securities and Exchange Commission (\u201cSEC\u201d), including its Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent SEC filings. In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. Except as required by law, Caribou undertakes no obligation to update publicly any forward-looking statements for any reason. Caribou Biosciences, Inc. contacts: Investors: Amy Figueroa, CFA investor.relations@cariboubio.com Media: Peggy Vorwald, PhD media@cariboubio.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CRBU", "date": "2025-01-13T00:05:00+00:00", "sentiment": {"score": 0.6920465044677258, "confidence": 0.7011003494262695, "probabilities": {"positive": 0.7011003494262695, "negative": 0.009053844958543777, "neutral": 0.2898457944393158}}, "embedding": [-0.0956369936466217, -0.08504923433065414, 0.07470299303531647, 0.0224226713180542, -0.03308720514178276, -0.08763987571001053, -0.20590874552726746, 0.22080428898334503, 0.04693104326725006, -0.017636215314269066, -0.09726135432720184, 0.02509048394858837, 0.058741725981235504, -0.01110778283327818, -0.047918349504470825, 0.09020711481571198, 0.04439668357372284, -0.02033132128417492, -0.04836723580956459, 0.05953734740614891, -0.0881410464644432, -0.03998197987675667, -0.019107632339000702, 0.11429294943809509, -0.017585182562470436, -0.017264006659388542, -0.18676243722438812, -0.0027961754240095615, -0.20498773455619812, -0.05205473303794861, 0.13596603274345398, 0.1044900119304657, -0.05011821910738945, 0.021198567003011703, 0.0005791466683149338, -0.08931843936443329, -0.08149795234203339, 0.02557099238038063, -0.05115769803524017, -0.07289345562458038, 0.03929554671049118, -0.10714303702116013, -0.11527233570814133, -0.01532731857150793, 0.053532674908638, -0.09884117543697357, -0.14185002446174622, 0.1151735782623291, -0.08609113842248917, 0.1393590271472931, -0.034376464784145355, -0.02891242876648903, -0.02000829018652439, 0.19339948892593384, -0.07725173234939575, 0.0020386776886880398, -0.06628894805908203, 0.06112657114863396, 0.15171626210212708, 0.008564689196646214, -0.15526920557022095, 0.01426924578845501, 0.02174137718975544, -0.07352788746356964, 0.08049653470516205, -0.030340269207954407, -0.08088476955890656, -0.11976691335439682, -0.01887165568768978, 0.07598236948251724, 0.06343264132738113, -0.023831656202673912, 0.06332658231258392, 0.02428022213280201, -0.05130942910909653, 0.16253450512886047, 0.03246799111366272, 0.11210839450359344, 0.044855814427137375, -0.08017519116401672, 0.03484358638525009, 0.03184977173805237, 0.08395174890756607, -0.14229893684387207, 0.02362648956477642, -0.011227366514503956, -0.031249435618519783, 0.0956137627363205, -0.09523142129182816, 0.04071013629436493, 0.15720506012439728, -0.06781332939863205, 0.055864982306957245, 0.0664883628487587, -0.10322540253400803, -0.041051581501960754, -0.003009890438988805, -0.04410918802022934, 0.07626654207706451, -0.03709786385297775, -0.01736236922442913, -0.0614340677857399, 0.049861449748277664, -0.1148475855588913, -0.03960433602333069, -0.03417075425386429, 0.07781947404146194, -0.0632980614900589, -0.0452558733522892, -0.11051321029663086, 0.15400740504264832, 0.0642874538898468, 0.06633823364973068, -0.004887939430773258, -0.04861283302307129, 0.1657041609287262, -0.10260181128978729, 0.020323093980550766, 0.14906200766563416, 0.02308119274675846, 0.1056567132472992, -0.0063625965267419815, 0.023219222202897072, -0.19162562489509583, 0.0856194943189621, 0.08336647599935532, -0.07568350434303284, 1.2168849028142819e-32, 0.05717424303293228, -0.00409852247685194, -0.01673019491136074, 0.04320480674505234, -0.09972657263278961, 0.023147594183683395, -0.017977269366383553, 0.07214482128620148, -0.10255777090787888, -0.1442663073539734, 0.0841759592294693, 0.05617144703865051, 0.10294731706380844, 0.13044200837612152, -0.2042870819568634, 0.001269604079425335, -0.08169741928577423, -0.04098007082939148, 0.00856611505150795, -0.06099393963813782, 0.07505081593990326, -0.11955517530441284, -0.057784080505371094, -0.06130276247859001, 0.015745267271995544, 0.14383038878440857, 0.010882537811994553, 0.0011057881638407707, 0.05161241069436073, 0.09044896066188812, -0.10922997444868088, 0.1234935000538826, 0.012885558418929577, 0.0245186947286129, -0.0399726927280426, -0.03602467477321625, 0.011566763743758202, -0.1025359034538269, 0.06216975301504135, 0.07118655741214752, 0.11123300343751907, 0.04233294725418091, -0.18473805487155914, -0.11602070927619934, 0.14491033554077148, -0.03968781232833862, -0.033048033714294434, -0.07404179871082306, 0.0038819287437945604, 0.08183012157678604, 0.05879281461238861, -0.1361664980649948, 0.05293300002813339, -0.048247553408145905, 0.04980591684579849, 0.03539915010333061, -0.15161630511283875, -0.10589613020420074, 0.06671274453401566, 0.07919338345527649, 0.10115888714790344, 0.1395101249217987, -0.021910415962338448, -0.04292944073677063, -0.027478504925966263, 0.0398622490465641, -0.09424261748790741, -0.0798296108841896, -0.08958498388528824, -0.011982565745711327, 0.0013775397092103958, -0.16474968194961548, 0.33182045817375183, 0.07856152206659317, 0.06793960928916931, 0.0053137727081775665, 0.20459268987178802, 0.07454731315374374, -0.06032221391797066, 0.044469308108091354, -0.009290365502238274, 0.02528373897075653, -0.1449197232723236, 0.16202373802661896, 0.07982306182384491, -0.16950902342796326, 0.009022536687552929, -0.09155677258968353, -0.25646889209747314, -0.05093268305063248, 0.13789807260036469, -0.04773310571908951, -0.04460009187459946, 0.17629355192184448, -0.09293726086616516, -1.194251493773168e-32, 0.07799682766199112, 0.052455827593803406, -0.007047765422612429, 0.0017709285020828247, 0.010969803668558598, 0.04839375242590904, 0.21357885003089905, -0.18983103334903717, 0.22205422818660736, -0.16056345403194427, 0.05435376986861229, 0.03997906297445297, -0.07292091846466064, 0.04056166112422943, 0.007240884937345982, -0.0072649819776415825, -0.046926099807024, -0.09363411366939545, -0.1759781390428543, 0.08880211412906647, 0.044425662606954575, 0.05747982859611511, -0.05425245314836502, 0.09746704995632172, 0.1350938081741333, 0.04069868475198746, 0.05746878311038017, -0.028054770082235336, 0.11455260217189789, -0.046978678554296494, -0.1427827626466751, 0.04867129027843475, -0.11349911987781525, -0.0815608948469162, -0.037414830178022385, 0.058843743056058884, 0.05740710720419884, -0.07663692533969879, 0.01798568107187748, -0.04308754578232765, -0.05825641378760338, -0.032161831855773926, -0.14480586349964142, -0.015506533905863762, 0.07767023146152496, 0.08089286088943481, 0.1389910727739334, 0.006811507977545261, 0.116674043238163, -0.010795713402330875, 0.036196477711200714, 0.011488782241940498, -0.07059045135974884, 0.05433584004640579, -0.0034401859156787395, -0.1477452516555786, 0.1030125766992569, -0.04795902222394943, -0.207039475440979, 0.03691950812935829, -0.013647318817675114, 0.18102172017097473, 0.08720626682043076, -0.06795346736907959, 0.10521334409713745, 0.11982345581054688, 0.10585375130176544, -0.159730926156044, 0.10373780876398087, -0.07415097951889038, -0.10354698449373245, -0.01665019989013672, 0.04109077528119087, -0.10098761320114136, 0.10700888186693192, 0.11330686509609222, -0.07075273245573044, -0.13213934004306793, -0.16846038401126862, -0.11665990203619003, -0.014427044428884983, -0.12127481400966644, 0.022529687732458115, 0.05890992283821106, 0.03951333090662956, 0.08145779371261597, -0.1235799491405487, -0.06561324000358582, 0.03171364963054657, 0.0832103043794632, -0.06990513205528259, -0.02589978650212288, -0.009323976933956146, 0.17605465650558472, 0.061289578676223755, -1.0017581786314622e-07, 0.1779474914073944, -0.02870006673038006, -0.009631955064833164, -0.1611732542514801, 0.0492209792137146, 0.022319329902529716, -0.02236536331474781, 0.03542279079556465, -0.006260048598051071, 0.14104929566383362, 0.09126892685890198, 0.152920201420784, -0.016574814915657043, -0.056080639362335205, 0.0242984090000391, 0.06786113977432251, 0.0555657222867012, -0.12774239480495453, -0.05515410751104355, 0.04980073496699333, -0.09610466659069061, 0.009185666218400002, 0.011002004146575928, -0.15414339303970337, 0.1426328867673874, -0.16505354642868042, 0.04874270036816597, 0.06619702279567719, 0.02455821819603443, -0.10828737914562225, 0.056557513773441315, -0.020263876765966415, 0.002589937299489975, -0.04274298995733261, 0.07250578701496124, -0.12360545992851257, 0.07124191522598267, 0.12234614789485931, 0.02362058311700821, 0.11951914429664612, 0.06733117997646332, 0.1569361686706543, -0.033016324043273926, -0.006124377250671387, -0.014063337817788124, -0.0941818505525589, -0.18432079255580902, 0.05315103381872177, 0.0684504434466362, -0.18142643570899963, -0.14449548721313477, -0.0007561203092336655, -0.17967630922794342, -0.026627149432897568, -0.004150908440351486, 0.20692279934883118, -0.038191210478544235, -0.08227957785129547, 0.05373499169945717, -0.11616699397563934, 0.05986949801445007, -0.06801828742027283, -0.014628062024712563, -0.031490832567214966], "changes": {"1wk": -1.2903213897927004}}, {"text": "PREMIUM BofA Securities Cuts Price Target on Caribou Biosciences to $11 From $13, Maintains Buy Rating MT Newswires Tue, Jan 7, 2025, 6:40 PM In This Article: CRBU -4.20% Caribou Biosciences (CRBU) has an average rating of buy and mean price target of $13.25, according t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CRBU", "date": "2025-01-07T15:40:28+00:00", "sentiment": {"score": 0.048518010415136814, "confidence": 0.06401784718036652, "probabilities": {"positive": 0.06401784718036652, "negative": 0.015499836765229702, "neutral": 0.920482337474823}}, "embedding": [-0.07455851137638092, -0.034225933253765106, -0.13906052708625793, 0.08865157514810562, 0.18189097940921783, 0.11812444776296616, -0.017195653170347214, 0.19549869000911713, -0.04795675352215767, 0.011107932776212692, 0.015626050531864166, -0.17317931354045868, 0.006777971051633358, -0.058884698897600174, -0.0042112418450415134, -0.046663716435432434, 0.07539000362157822, -0.16724959015846252, 0.10867235064506531, 0.02334035374224186, -0.2546120882034302, 0.06782732903957367, 0.0051351445727050304, 0.17784646153450012, 0.15057961642742157, -0.1736099123954773, -0.1229877844452858, -0.026895910501480103, 0.00892130471765995, 0.039775051176548004, 0.0065725441090762615, 0.03230023756623268, 0.1440577656030655, -0.12812192738056183, 0.10025516152381897, -0.10769771039485931, -0.10070163756608963, -0.14762291312217712, -0.12488198280334473, 0.04549918696284294, 0.06906475871801376, 0.05684226006269455, -0.2652221918106079, 0.029393216595053673, -0.02377166599035263, -0.08352161198854446, 0.1061752438545227, 0.15335886180400848, 0.13957147300243378, 0.05986039713025093, -0.19422970712184906, -0.16767778992652893, -0.04077756032347679, -0.015212531201541424, -0.01663167215883732, 0.09901432693004608, -0.21079762279987335, -0.05535544827580452, 0.16790403425693512, -0.03532055765390396, -0.03974959999322891, -0.07736293226480484, 0.03011481463909149, -0.014792770147323608, 0.1351199448108673, -0.05080587416887283, -0.22092418372631073, -0.0019043250940740108, 0.014776996336877346, -0.029450295493006706, 0.05494997650384903, 0.015318917110562325, 0.13752490282058716, -0.05481168255209923, 0.04444129019975662, 0.19859127700328827, 0.05501057952642441, -0.08810395747423172, 0.12014728784561157, -0.020274894312024117, -0.09670732915401459, -0.2733169496059418, 0.016191136091947556, -0.15615031123161316, 0.08956851065158844, -0.08588369935750961, 0.31559857726097107, -0.1005750447511673, -0.06414930522441864, 0.025657495483756065, 0.28693345189094543, -0.15828421711921692, 0.06122424453496933, -0.12350202351808548, -0.2726597785949707, -0.0023094485513865948, -0.07883196324110031, -0.14150460064411163, -0.0103306220844388, -0.022176701575517654, -0.03281356394290924, 0.014837652444839478, 0.05039389804005623, 0.006939580198377371, -0.12186957895755768, -0.15517424046993256, -0.06620088964700699, 0.20533686876296997, 0.08219236135482788, 0.1859103888273239, -0.12146656960248947, 0.14593815803527832, 0.034530892968177795, -0.11443229019641876, -0.10278184711933136, 0.17300912737846375, -0.1729302704334259, -0.06368136405944824, 0.15606506168842316, -0.07418305426836014, 0.06469660997390747, -0.009479880332946777, 0.008381448686122894, -0.09756842255592346, -0.08309517055749893, -0.00966712273657322, -0.17812885344028473, 1.4944651837282968e-32, 0.15900848805904388, 0.0994928777217865, -0.023803574964404106, -0.26618924736976624, -0.11739715933799744, -0.0053090425208210945, -0.15940049290657043, -0.02093098871409893, 0.003893128363415599, 0.009664306417107582, -0.19075866043567657, 0.1421014815568924, 0.05622699111700058, 0.17773151397705078, -0.04488888010382652, -0.1852009892463684, -0.2751716077327728, -0.04536623880267143, 0.05198852717876434, 0.1614851951599121, -0.0945303812623024, 0.02384648099541664, -0.06927752494812012, 0.10793507099151611, -0.0360596626996994, -0.012371269054710865, 0.11679293215274811, 0.035477716475725174, 0.04101034253835678, 0.12998178601264954, -0.0600556805729866, -0.0028547148685902357, 0.0040712361223995686, -0.08247081190347672, 0.03161632642149925, -0.09555546194314957, 0.009880682453513145, -0.11933360993862152, -0.07532209157943726, -0.0805559828877449, 0.19613835215568542, 0.010673753917217255, -0.1481965184211731, -0.10664994269609451, 0.1583753377199173, -0.04763170704245567, 0.18413424491882324, -0.07723098993301392, 0.026473866775631905, -0.06950844824314117, -0.15117846429347992, 0.02486639842391014, -0.09523707628250122, 0.051278624683618546, -0.13899488747119904, -0.04919856786727905, -0.06632593274116516, -0.1700325906276703, 0.12338124960660934, 0.03883826732635498, 0.15788395702838898, 0.163652703166008, 0.1761873960494995, -0.12257033586502075, -0.19006121158599854, 0.17631708085536957, -0.13534623384475708, -0.07736784964799881, -0.08294021338224411, 0.0608442984521389, 0.10739649832248688, -0.02597186528146267, 0.1396789848804474, -0.12341584265232086, 0.020002221688628197, -0.05583563819527626, 0.04606816917657852, 0.10016417503356934, 0.10836048424243927, -0.0370100736618042, -0.01061508059501648, 0.05244138464331627, 0.258566290140152, -0.04293697699904442, 0.10414091497659683, -0.050864651799201965, -0.1700419783592224, 0.032926395535469055, -0.08652292191982269, -0.03346304967999458, 0.07165239006280899, -0.02912544086575508, -0.046095263212919235, 0.06919786334037781, 0.008102023042738438, -1.3410596444629358e-32, -0.11805453896522522, -0.0976020097732544, 0.1604965776205063, 0.07494832575321198, -0.057733725756406784, 0.02133856900036335, 0.01817215047776699, 0.0917307585477829, 0.2752542197704315, 0.03529566153883934, -0.08015140146017075, 0.21953363716602325, -0.1385093778371811, 0.0024794095661491156, 0.17851582169532776, 0.005569729488343, -0.05136870965361595, -0.08492754399776459, -0.0622282400727272, -0.11688416451215744, -0.12410914897918701, 0.11292359232902527, -0.010547660291194916, 0.17063608765602112, 0.14431171119213104, 0.09798765182495117, 0.06458510458469391, 0.055762454867362976, 0.14828979969024658, -0.02125951647758484, -0.12577898800373077, -0.026015864685177803, -0.17965185642242432, 0.16186659038066864, -0.14321337640285492, -0.041287388652563095, 0.11460602283477783, 0.04721455276012421, -0.05669671669602394, 0.11474649608135223, 0.11681909114122391, -0.058025043457746506, -0.14616334438323975, -0.09326377511024475, 0.07969100773334503, -0.14765411615371704, -0.050001680850982666, -0.0027331144083291292, 0.16581103205680847, 0.1285841166973114, 0.07365570217370987, 0.03597218543291092, 0.12567546963691711, -0.041691798716783524, -0.2478899210691452, 0.0011295543517917395, 0.05665934085845947, 0.19016443192958832, -0.008377793245017529, 0.14760172367095947, 0.21640154719352722, 0.24441590905189514, -0.05404707044363022, 0.009036872535943985, 0.04733029007911682, 0.17133694887161255, 0.14353962242603302, -0.006611135322600603, 0.02443459816277027, -0.13566109538078308, -0.018907738849520683, 0.0048328279517591, 0.1455826461315155, -0.12704797089099884, 0.004217003937810659, 0.18930990993976593, -0.14170615375041962, 0.019129503518342972, 0.009613796137273312, 0.101133331656456, 0.06227981299161911, -0.06042223051190376, 0.060341112315654755, 0.03911380469799042, -0.024228530004620552, -0.1490228772163391, -0.2067875862121582, -0.04552310332655907, -0.05506031960248947, 0.12709882855415344, -0.19932276010513306, -0.12213831394910812, 0.0966201201081276, 0.11561322212219238, 0.09395500272512436, -9.948669088544193e-08, 0.13398313522338867, -0.02779649756848812, 0.11893945932388306, 0.12993739545345306, 0.12731191515922546, 0.0769980400800705, -0.0985703244805336, -0.03716578334569931, -0.00012667231203522533, 0.09819379448890686, -0.026542166247963905, -0.007659038994461298, -0.08219904452562332, 0.07103681564331055, -0.10790923237800598, -0.037154026329517365, 0.002318602055311203, 0.025383539497852325, -0.06017126888036728, 0.03916609659790993, 0.059329889714717865, 0.09835256636142731, 0.10177920758724213, 0.04579702019691467, -0.016801822930574417, -0.08355404436588287, 0.03885892778635025, 0.15452225506305695, -0.02686145529150963, 0.09444397687911987, -0.05866212397813797, -0.0036587449721992016, 0.028070231899619102, -0.02774910256266594, 0.01729573868215084, 0.023234615102410316, -0.06585551053285599, 0.08768847584724426, -0.1672811210155487, 0.17073525488376617, 0.06664489209651947, -0.13234367966651917, -0.05350101366639137, -0.04756951704621315, -0.062402065843343735, 0.07376217097043991, -0.2419799417257309, 0.023672381415963173, 0.11637641489505768, -0.0373118557035923, 0.14783143997192383, 0.0034515252336859703, -0.08259628713130951, 0.11724016815423965, -0.041820377111434937, -0.03545238450169563, -0.08237763494253159, -0.20304140448570251, -0.07426806539297104, 0.04102436080574989, 0.032823365181684494, -0.3587249517440796, 0.12889254093170166, 0.11338038742542267], "changes": {"1wk": -16.577543379591}}, {"text": "Caribou Biosciences to Present at 43rd Annual J.P. Morgan Healthcare Conference Caribou Biosciences, Inc. Wed, Jan 8, 2025, 12:00 AM 2 min read In This Article: CRBU -4.20% Caribou Biosciences, Inc. BERKELEY, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced that Rachel Haurwitz, PhD, Caribou\u2019s president and chief executive officer, is scheduled to present a corporate update at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16, 2025 at 10:30 am PST. For more information and a link to the live webcast , visit the Events page on Caribou\u2019s website. Webcasts will be available on the Caribou website for 30 days after the event. About Caribou\u2019s novel next-generation CRISPR platform CRISPR genome editing uses easily designed, modular biological tools to make DNA changes in living cells. There are two basic components of Class 2 CRISPR systems: the nuclease protein that cuts DNA and the RNA molecule(s) that guide the nuclease to generate a site-specific, double-stranded break, leading to an edit at the targeted genomic site. CRISPR systems are capable of editing unintended genomic sites, known as off-target editing, which may lead to harmful effects on cellular function and phenotype. In response to this challenge, Caribou has developed CRISPR hybrid RNA-DNA guides (chRDNAs; pronounced \u201cchardonnays\u201d) that direct substantially more precise genome editing compared to all-RNA guides. Caribou is deploying the power of its chRDNA technology to carry out high efficiency multiple edits, to develop CRISPR-edited therapies. About Caribou Biosciences, Inc. Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company\u2019s genome-editing platform, including its Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve activity against disease. Caribou is advancing a pipeline of off-the-shelf cell therapies from its CAR-T platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases.\u00a0Follow us @CaribouBio and visit www.cariboubio.com . Caribou Biosciences, Inc. contacts: Investors: Amy Figueroa, CFA investor.relations@cariboubio.com Media: Peggy Vorwald, PhD media@cariboubio.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CRBU", "date": "2025-01-07T21:00:00+00:00", "sentiment": {"score": 0.08676168974488974, "confidence": 0.09870671480894089, "probabilities": {"positive": 0.09870671480894089, "negative": 0.011945025064051151, "neutral": 0.8893482089042664}}, "embedding": [-0.0819438099861145, -0.07949890196323395, -0.05460667237639427, -0.09782949090003967, 0.0824107825756073, 0.008916618302464485, -0.24784207344055176, 0.058740369975566864, -0.04527110978960991, 0.07403510808944702, -0.13309578597545624, 0.024456508457660675, -0.005157014355063438, -0.020597122609615326, -0.09489123523235321, 0.034208595752716064, -0.2102125585079193, 0.0569738894701004, -0.12006475776433945, 0.001586991362273693, -0.01171397976577282, 0.16094407439231873, 0.08923721313476562, 0.10154789686203003, -0.1250435709953308, -0.1415080726146698, -0.06974683701992035, -0.046096786856651306, -0.2082434892654419, -0.08097964525222778, 0.06552642583847046, 0.05515259504318237, 0.059804096817970276, -0.13755285739898682, 0.033159151673316956, 0.012659519910812378, 0.010203284211456776, -0.02531544119119644, 0.010962003841996193, -0.07818818092346191, -0.02792852558195591, -0.10425485670566559, -0.08178785443305969, 0.12912482023239136, 0.016910463571548462, 0.035939909517765045, -0.016141045838594437, -0.0064966087229549885, -0.012181460857391357, -0.015351176261901855, -0.24395796656608582, -0.17561641335487366, -0.04020416736602783, -0.05288431793451309, 0.021549774333834648, 0.10851649940013885, -0.06810607761144638, 0.037695735692977905, 0.17544083297252655, -0.10420574247837067, 0.05442577973008156, -0.09635179489850998, 0.07467435300350189, 0.002601839601993561, 0.045932769775390625, -0.07947215437889099, 0.048445962369441986, -0.054886654019355774, 0.036118034273386, -0.04071177542209625, 0.05174554884433746, 0.004421929828822613, 0.16280502080917358, 0.07795493304729462, 0.01118946261703968, 0.07674728333950043, 0.007951490581035614, 0.1739385724067688, 0.15644249320030212, -0.03791636601090431, 0.02476445585489273, -0.1439923644065857, 0.13300149142742157, -0.09672877192497253, 0.020683323964476585, 0.04841509461402893, 0.12404075264930725, -0.0218772254884243, 0.004627905786037445, 0.06288272142410278, 0.17633704841136932, -0.04745160788297653, 0.14067411422729492, -0.06135790795087814, -0.3409135937690735, -0.06823346763849258, 0.10071572661399841, -0.02997967228293419, 0.08291743695735931, -0.05416944622993469, -0.026517469435930252, 0.059919342398643494, 0.050984855741262436, -0.05738268792629242, 0.06430992484092712, -0.009612943977117538, -0.053678762167692184, 0.065071702003479, 0.048464443534612656, 0.03823162615299225, -0.021898820996284485, 0.13599258661270142, -0.014036692678928375, -0.061576053500175476, -0.07164551317691803, 0.10985331237316132, 0.011930445209145546, 0.057478733360767365, 0.1183716207742691, 0.05629948526620865, 0.06295222043991089, -0.060899633914232254, 0.006558686029165983, -0.11205171048641205, -0.0654822587966919, -0.01470168586820364, -0.19433259963989258, 8.524441117085433e-33, 0.049600113183259964, 0.12087852507829666, 0.050076913088560104, 0.004043180495500565, 0.020316798239946365, -0.14116548001766205, -0.1502777636051178, 0.06351594626903534, -0.04421946033835411, -0.14302045106887817, -0.04696911200881004, -0.05058130621910095, 0.06961182504892349, 0.20686283707618713, -0.02698497474193573, -0.10100048780441284, -0.20203256607055664, -0.03425641357898712, -0.18685424327850342, 0.02657502517104149, -0.006377900019288063, 0.030312124639749527, -0.009346510283648968, 0.08350998908281326, 0.06601154804229736, 0.049662720412015915, 0.08862718939781189, 0.05788176506757736, 0.11297903954982758, 0.04721634462475777, -0.09103751182556152, 0.05368088185787201, -0.05185855180025101, -0.06127860024571419, 0.028809625655412674, -0.09254856407642365, 0.03213650360703468, -0.22083447873592377, 0.00039379578083753586, 0.10200530290603638, 0.04713698849081993, -0.022654207423329353, -0.12741263210773468, -0.14462167024612427, 0.1428886353969574, -0.06379325687885284, 0.10055539757013321, 0.14906278252601624, -0.0254179947078228, -0.022155918180942535, 0.03479417413473129, -0.043766990303993225, -0.007985902950167656, 0.0001883525401353836, 0.003895967733114958, 0.07270623743534088, -0.06198040395975113, -0.2237943708896637, 0.09717962145805359, 0.08748173713684082, 0.1388682723045349, 0.11266426742076874, 0.019319696351885796, 0.049528270959854126, -0.07919054478406906, 0.08675223588943481, -0.010991856455802917, -0.09170207381248474, 0.11792412400245667, 0.015589850023388863, -0.02299189567565918, -0.08098950237035751, 0.1727306842803955, 0.010853859595954418, -0.01619841903448105, -0.08753758668899536, 0.05656048282980919, 0.0964057445526123, -0.04454880207777023, 0.009180265478789806, 0.11613889038562775, 0.10298652946949005, -0.09772740304470062, 0.036410775035619736, 0.030593033879995346, -0.16858968138694763, -0.01706257276237011, 0.05605670437216759, -0.22283846139907837, -0.009566422551870346, 0.07805706560611725, -0.12794950604438782, 0.09309051185846329, 0.035560593008995056, 0.01191051583737135, -8.161367646314892e-33, -0.03565502166748047, -0.15589287877082825, -0.003191187046468258, 0.09285371750593185, -0.04946095868945122, 0.03571770340204239, 0.02529594674706459, -0.18395239114761353, 0.09223151206970215, -0.3064521849155426, 0.026422811672091484, 0.08830566704273224, 0.05594058334827423, -0.07601568847894669, -0.06667433679103851, 0.027498070150613785, -0.002299646846950054, -0.13952207565307617, -0.3025820553302765, -0.0030827168375253677, 0.014974401332437992, 0.06179958954453468, -0.1072956919670105, 0.06315620243549347, 0.06787463277578354, 0.06041976809501648, -0.04308305308222771, 0.14734797179698944, 0.18946465849876404, -0.028335368260741234, -0.10128310322761536, 0.05229795351624489, -0.2080630511045456, 0.028054850175976753, 0.017456503584980965, -0.01982356421649456, 0.023760013282299042, -0.12080968916416168, 0.054725248366594315, -0.028078284114599228, 0.16234612464904785, 0.027331506833434105, -0.20917238295078278, 0.03263745456933975, 0.01675635576248169, 0.11135055124759674, -0.003860202617943287, 0.04634200781583786, 0.11251730471849442, 0.043899308890104294, 0.07125083357095718, 0.026090003550052643, -0.12814588844776154, -0.02563648298382759, 0.04020841792225838, -0.009310856461524963, 0.0397275909781456, -0.11109508574008942, -0.021571289747953415, 0.08720362186431885, -0.06277495622634888, 0.061975207179784775, 0.048700615763664246, 0.03142140433192253, 0.13137979805469513, 0.06025082617998123, 0.024034548550844193, 0.014130892232060432, 0.09590038657188416, -0.09647354483604431, -0.011453598737716675, 0.026349246501922607, 0.18184298276901245, -0.0904635637998581, -0.01452364306896925, 0.01868695393204689, -0.1327996850013733, -0.12953734397888184, -0.16317862272262573, -0.03121037222445011, 0.05241966247558594, -0.15940344333648682, 0.12243027240037918, 0.043134432286024094, 0.050403717905282974, 0.08605801314115524, -0.04468177631497383, -0.05154278874397278, 0.025125419721007347, -0.025003913789987564, -0.0930393785238266, -0.009136930108070374, -0.020808279514312744, 0.25243979692459106, 0.008981218561530113, -9.981773985145992e-08, 0.29146409034729004, -0.021930042654275894, -0.08224770426750183, -0.16602131724357605, -0.0052089025266468525, -0.034018319100141525, -0.08574964106082916, 0.05633891746401787, -0.049726344645023346, 0.06974731385707855, 0.06322810053825378, 0.15078423917293549, -0.06767229735851288, 0.06613168120384216, 0.0844997763633728, 0.1761467605829239, -0.006057375110685825, 0.05501154065132141, -0.09223036468029022, 0.10770001262426376, -0.08890269696712494, 0.04739027097821236, -0.11913371086120605, 0.02267863228917122, 0.11466026306152344, -0.12220674753189087, 0.0459047332406044, 0.10787985473871231, 0.02397826500236988, -0.08367336541414261, 0.02451140061020851, -0.07670009881258011, 0.1151985451579094, 0.12350427359342575, -0.022792667150497437, -0.05457106605172157, 0.05782771855592728, 0.09184731543064117, -0.0290532186627388, 0.22685390710830688, 0.13798408210277557, 0.04277200996875763, -0.10298904776573181, 0.04679417610168457, -0.13759957253932953, -0.13078190386295319, -0.06624610722064972, 0.014932775869965553, -0.05408865958452225, 0.05885948985815048, -0.12138389050960541, 0.16532203555107117, -0.06820167601108551, -0.02854170650243759, -0.03187202289700508, 0.25669634342193604, -0.06193370372056961, -0.10230878740549088, 0.0032567332964390516, 0.029525501653552055, -0.007592068053781986, -0.07564668357372284, 0.18788015842437744, 0.014601407572627068], "changes": {"1wk": -16.577543379591}}, {"text": "PREMIUM Caribou Biosciences Names Sri Ryali CFO MT Newswires Thu, Jan 2, 2025, 4:45 PM In This Article: CRBU -4.20% CDXS +1.91% Caribou Biosciences (CRBU) said Thursday it has appointed Sri Ryali as chief financial officer. R PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CRBU", "date": "2025-01-02T13:45:55+00:00", "sentiment": {"score": 0.04506078269332647, "confidence": 0.05701107531785965, "probabilities": {"positive": 0.05701107531785965, "negative": 0.011950292624533176, "neutral": 0.9310386776924133}}, "embedding": [-0.09884797036647797, -0.07504206895828247, -0.06539607793092728, 0.003457797924056649, 0.05893159285187721, 0.11190985888242722, 0.009587718173861504, 0.14008331298828125, -0.14876621961593628, 0.028637278825044632, -0.031341396272182465, -0.1301203817129135, 0.02164006046950817, 0.046699877828359604, -0.13285163044929504, -0.09701845049858093, 0.04213404282927513, -0.0736764669418335, 0.09101013839244843, -0.01668698340654373, -0.16372236609458923, -0.007850377820432186, -0.03636053577065468, -0.024509895592927933, 0.08521895110607147, -0.031190818175673485, -0.1664523035287857, 0.015687862411141396, -0.000609349925071001, 0.00041216661338694394, 0.11285483837127686, 0.10888313502073288, 0.10490923374891281, -0.1489085704088211, 0.12879590690135956, 0.019056225195527077, -0.1256951093673706, -0.04965583607554436, -0.026920147240161896, 0.0012694236356765032, 0.020917478948831558, -0.09358306229114532, 0.031643711030483246, 0.0361749529838562, -0.0574820414185524, -0.06533645838499069, 0.11663597822189331, -0.019623510539531708, 0.04426084831357002, -0.02300095744431019, -0.18814359605312347, -0.1946517378091812, 0.02325362153351307, -0.037607982754707336, 0.024809671565890312, 0.09198470413684845, -0.033367305994033813, -0.08911094069480896, 0.030069386586546898, -0.1963825672864914, -0.045662734657526016, -0.04243433102965355, -0.022050123661756516, 0.13730691373348236, 0.07281538099050522, -0.038715261965990067, -0.134353369474411, 0.07388316094875336, 0.06405702978372574, -0.012640377506613731, 0.045548275113105774, 0.027042482048273087, 0.02066713012754917, 0.01990773342549801, 0.027436252683401108, 0.21735259890556335, 0.00685756653547287, 0.08754082769155502, 0.16290687024593353, -0.07409872859716415, 0.006048114504665136, -0.024087220430374146, 0.08300235867500305, -0.1341528743505478, 0.01120917871594429, 0.10140000283718109, 0.17049917578697205, -0.1654938906431198, -0.09093157947063446, -0.09914746880531311, 0.3408549726009369, -0.08900253474712372, 0.12121302634477615, -0.057846058160066605, -0.2580331563949585, -0.017653971910476685, -0.038026824593544006, -0.07659810781478882, -0.05157455801963806, -0.052851948887109756, -0.0768950879573822, 0.08751741051673889, -0.10660052299499512, 0.08256267756223679, -0.15980206429958344, -0.05079975724220276, -0.16090933978557587, 0.18060562014579773, 0.04857446253299713, 0.07394462823867798, -0.1609840840101242, 0.19940505921840668, -0.0889277383685112, -0.05159531533718109, -0.09361175447702408, 0.1441756933927536, -0.16061635315418243, 0.0662551298737526, 0.0892900601029396, -0.06117246299982071, -0.01805838756263256, -0.02315683849155903, -0.14042127132415771, -0.1254645735025406, 0.0984792560338974, 0.004074313677847385, -0.14146414399147034, 1.5672093291977894e-32, 0.06435701996088028, 0.1703162044286728, 0.11885736137628555, -0.126092329621315, 0.05437502637505531, -0.02863592654466629, -0.19476968050003052, -0.10898774862289429, 0.0005457953666336834, 0.010013316757977009, -0.15302594006061554, 0.11000075191259384, 0.07038561254739761, 0.04424380138516426, -0.2391345202922821, -0.017090817913413048, -0.2526843845844269, 0.03169800713658333, -0.08887391537427902, 0.05666100233793259, 0.036898475140333176, 0.101163849234581, 0.08962856233119965, 0.1203627735376358, 0.03969782590866089, 0.04955309256911278, 0.18222954869270325, 0.04235035181045532, 0.1282925307750702, 0.19375759363174438, 0.016439922153949738, -0.06694596260786057, -0.09278294444084167, -0.07480426132678986, 0.11891049891710281, -0.04857730492949486, -0.08871086686849594, -0.1536906510591507, -0.05393592640757561, 0.14671315252780914, 0.12485800683498383, -0.044847600162029266, -0.15659362077713013, -0.0011668384540826082, 0.032668787986040115, -0.10600724816322327, 0.1620732545852661, 0.009316683746874332, 0.1596684604883194, -0.05899669975042343, -0.11191251128911972, -0.0042935688979923725, -0.03801633045077324, -0.027846647426486015, 0.08619272708892822, 0.04284327104687691, -0.038387373089790344, -0.10859473794698715, 0.05810817703604698, -0.035181451588869095, 0.05800479277968407, 0.1541457623243332, -0.02104746736586094, -0.10045956820249557, -0.05743309482932091, 0.05783788487315178, -0.08014022558927536, -0.21762283146381378, 0.16701045632362366, -0.019637789577245712, 0.09149273484945297, -0.09955231100320816, 0.15821979939937592, 0.035668473690748215, -0.008534567430615425, 0.02282230742275715, 0.06500706076622009, 0.05454397201538086, -0.049004945904016495, 0.06957018375396729, -0.06470677256584167, 0.10832518339157104, 0.14527559280395508, 0.0016558242496103048, 0.14882469177246094, -0.1507941037416458, -0.1322525143623352, -0.06443597376346588, 0.03369005024433136, 0.07983264327049255, 0.014231649227440357, -0.006129702087491751, -0.0019269752083346248, 0.1528046727180481, -0.16698861122131348, -1.501348878646712e-32, -0.08750209957361221, -0.0704168751835823, 0.06176341325044632, 0.01937752589583397, -0.06383546441793442, 0.009064091369509697, -0.03691266104578972, 0.06026628613471985, 0.25449034571647644, -0.10872618854045868, 0.09598357230424881, 0.17266127467155457, -0.0843469500541687, -0.07596701383590698, 0.18334724009037018, 0.12628068029880524, 0.04619535431265831, -0.06778247654438019, -0.2854434549808502, 0.03956221044063568, -0.02981635183095932, 0.029376180842518806, -0.004087905399501324, 0.14689627289772034, 0.20100325345993042, 0.06912464648485184, 0.1097932755947113, 0.09418918192386627, 0.09135012328624725, -0.07700779289007187, -0.05413380637764931, -0.07446739077568054, -0.29343533515930176, 0.13178053498268127, -0.1467379927635193, -0.04899891838431358, 0.08481977134943008, 0.054462846368551254, -0.05995539575815201, 0.22070492804050446, 0.1691085547208786, 0.03708074241876602, -0.08742798119783401, -0.059021878987550735, 0.0021524217445403337, -0.22897280752658844, -0.08711470663547516, 0.009707026183605194, 0.09412848949432373, 0.005281988065689802, -0.038242653012275696, -0.06647709012031555, 0.028592528775334358, -0.004253132734447718, 0.0823865458369255, 0.08235834538936615, 0.046337421983480453, 0.13439971208572388, 0.06627747416496277, 0.12149634212255478, 0.2035854160785675, 0.1447991579771042, -0.08517561852931976, -6.445006874855608e-05, 0.0339810773730278, 0.10978734493255615, 0.13228212296962738, -0.08442853391170502, 0.03795865550637245, -0.13990706205368042, 0.1442279815673828, -0.024607094004750252, -0.019970277324318886, -0.1081366166472435, -0.029939433559775352, 0.15837804973125458, -0.31436946988105774, -0.06303642690181732, -0.17306816577911377, 0.05770042911171913, 0.0738682895898819, -0.04988076910376549, 0.030237875878810883, -0.00336629431694746, 0.040811602026224136, -0.04471493884921074, -0.11272149533033371, -0.14099985361099243, 0.09818267077207565, -0.021502165123820305, -0.07812836766242981, -0.17267927527427673, -0.08431413769721985, 0.18095730245113373, 0.20273712277412415, -9.979950021943296e-08, 0.1605709344148636, -0.15345416963100433, 0.037249766290187836, -0.053287677466869354, 0.14128120243549347, -0.04166484996676445, -0.11187681555747986, -0.10060562193393707, -0.021758215501904488, 0.11307394504547119, 0.09878790378570557, -0.0062923310324549675, 0.052879273891448975, 0.0018473698291927576, 0.04161554574966431, 0.0821133553981781, 0.007267981301993132, 0.10843578726053238, -0.1333068311214447, 0.04452156648039818, 0.011604586616158485, 0.08920218795537949, 0.0970333144068718, -0.05570394918322563, 0.01017518900334835, -0.1500353068113327, 0.06738611310720444, 0.04105692729353905, -0.06334083527326584, -0.006754946894943714, -0.07359146326780319, 0.10195742547512054, -0.020696396008133888, -0.023812133818864822, -0.05307630077004433, 0.039279378950595856, 0.09673839062452316, 0.06667384505271912, -0.04051988199353218, 0.08968637883663177, -0.04800434038043022, -0.020081710070371628, 0.07298022508621216, 0.11476515233516693, -0.11107072234153748, 0.059720247983932495, -0.08625703305006027, -0.010941678658127785, -0.0018098376458510756, -0.14678427577018738, 0.046922553330659866, -0.018847033381462097, -0.09510822594165802, 0.043868716806173325, -0.08930589258670807, 0.1073572114109993, -0.07547806948423386, -0.10999376326799393, -0.14892783761024475, -0.06345189362764359, -0.11204320192337036, -0.20991212129592896, 0.20425349473953247, -0.05564194917678833], "changes": {"1wk": 2.3809572804273027, "1mo": -14.880952845557763}}, {"text": "Why Is Caribou Biosciences Inc. (CRBU) Among the Top CRISPR Stocks to Invest In? Sheryar Siddiq Mon, Dec 30, 2024, 11:01 PM 5 min read In This Article: CRBU -4.20% We recently compiled a list of the Top 11 CRISPR Stocks to Invest In . In this article, we are going to take a look at where Caribou Biosciences Inc. (NASDAQ:CRBU) stands against the other CRISPR stocks. The pharmaceutical industry is buzzing with innovation, driven by the need for new treatments, tackling unmet medical challenges, and leveraging cutting-edge technologies like pharmacogenomics, digital therapeutics, and artificial intelligence. Among the most exciting breakthroughs are gene therapy and gene editing, with CRISPR-Cas9 leading the charge. This remarkable tool, inspired by bacteria's natural defenses, acts like precise genetic scissors\u2014faster, cheaper, and more accurate than other genome-editing methods. Back in 2014, CRISPR and its associated Cas proteins were mostly limited to academic research, generating a lot of excitement but seeming far from real-world applications. Just six years later, after earning a Nobel Prize, CRISPR began to make its way into over 20 clinical trials. The COVID-19 pandemic further demonstrated its potential, with CRISPR-based tests delivering quick and accurate virus detection, while experimental treatments explored its use against the virus\u2014showcasing the technology\u2019s incredible flexibility in tackling public health crises. The CRISPR technology market is poised for explosive growth. Coherent Market Insights estimates it will be worth $3.64 billion in 2024 and climb to more than $12.46 billion by 2031, growing at an impressive annual rate of 19.2%. Cell and gene therapies are game-changing for treating certain cancers and rare diseases. As of 2024, there are 38 FDA-approved cell and gene therapy products, including six CAR-T cell therapies targeting cancers like lymphoma, leukemia, and multiple myeloma. Several gene therapies are also available for rare genetic disorders, such as spinal muscular atrophy and Duchenne muscular dystrophy. The industry's focus has evolved from simply proving these therapies work to optimizing their effectiveness, minimizing side effects, and broadening their applications. However, these therapies can come with eye-watering price tags\u2014ranging from $400,000 to $2 million per dose. Although the sector has faced tough investment conditions since its boom in 2020 and 2021, there are signs of a rebound. Investments in the first half of 2024 reached $10.9 billion, surpassing 2019\u2019s $9.8 billion, though still shy of the record $19.9 billion and $22.7 billion seen in 2020 and 2021. Funding dipped to $12.6 billion in 2022 and $11.7 billion in 2023. But there\u2019s hope: Morgan Stanley suggests that Federal Reserve interest rate cuts could breathe new life into riskier assets like cell and gene therapies, aligning with a broader recovery in biotech. Story Continues The regulatory landscape for gene and regenerative therapies has also come a long way. In the U.S., the FDA has created clearer pathways for development, aided by the Regenerative Medicine Advanced Therapy (RMAT) designation, which speeds up review times and offers additional support to developers. Similarly, Europe has made strides with its guidelines for Advanced Therapy Medicinal Products (ATMPs). In 2017, the European Commission introduced a joint action plan to simplify processes for companies. While there\u2019s still progress to be made, the push toward harmonized international regulations has made it easier for companies to secure approvals across multiple regions. Our Methodology To identify the top 11 CRISPR stocks to invest in, we started by analyzing companies in the sector using ETF holdings and media coverage. We then narrowed down the list by focusing on top-performing stocks with the highest number of hedge fund investors, as tracked by Insider Monkey\u2019s database of 900 hedge funds at the end of Q3 2024. At Insider Monkey, we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter\u2019s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points ( see more details here ). A scientist in a lab holding a vial containing a CAR-T cell therapy. Caribou Biosciences Inc. (NASDAQ: CRBU ) Number of Hedge Fund Holders: 18 Caribou Biosciences, Inc. (NASDAQ:CRBU) is a clinical-stage biopharmaceutical company specializing in genome-edited allogeneic cell therapies for severe diseases. Unlike most CRISPR systems that use all-RNA guides, Caribou\u2019s proprietary chRDNA technology incorporates both RNA and DNA to enhance precision and minimize off-target effects. If the company\u2019s human leukocyte antigen (HLA) matching hypothesis is successful, it could position Caribou as a leader in next-generation cell therapies. The company currently has three clinical-stage allogeneic CAR-T cell therapies in phase 1 trials, targeting various hematologic cancers. Its lead candidate, CB-010, aimed at treating non-Hodgkin lymphoma, has been under clinical investigation since 2021. On the financial front, Caribou Biosciences, Inc. (NASDAQ:CRBU) ended the third quarter with $281 million in cash and equivalents, which it expects to sustain operations through the second half of 2026. R&D expenses rose to $30.4 million, driven by ongoing clinical trials, while licensing revenue declined due to the termination of a major agreement. Despite these financial shifts, the company remains committed to advancing its pipeline for long-term growth and innovation. Overall CRBU ranks 10th on our list of the top CRISPR stocks to invest in. While we acknowledge the potential of CRBU as an investment, our conviction lies in the belief that certain AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than CRBU but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock . READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock . Disclosure: None. This article is originally published at Insider Monkey . View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CRBU", "date": "2024-12-30T20:01:11+00:00", "sentiment": {"score": 0.3391736978664994, "confidence": 0.3509550988674164, "probabilities": {"positive": 0.3509550988674164, "negative": 0.011781401000916958, "neutral": 0.6372635364532471}}, "embedding": [-0.17479121685028076, -0.12015169113874435, -0.001375364139676094, -0.05319300293922424, 0.04145444184541702, 0.015692003071308136, -0.13553786277770996, 0.23726987838745117, 0.0844859853386879, 0.11888622492551804, -0.22156530618667603, 0.06836967915296555, 0.03570527955889702, 0.026894748210906982, -0.13259828090667725, 0.07659852504730225, -0.144918292760849, -0.005417220294475555, -0.0711536854505539, -0.042052630335092545, -0.13183161616325378, 0.13500909507274628, 0.157562255859375, 0.06126657873392105, -0.10223388671875, -0.072586290538311, -0.033609017729759216, -0.14920499920845032, -0.2809048891067505, -0.03269391506910324, 0.1384684145450592, 0.08085399121046066, 0.018660008907318115, -0.10912830382585526, -0.048640280961990356, -0.029281405732035637, -0.04116595908999443, -0.025670213624835014, 0.06829585880041122, -0.1037449911236763, -0.005446980707347393, -0.09268084168434143, -0.13120883703231812, 0.06002681329846382, 0.09733801335096359, -0.15290135145187378, -0.002182910218834877, -0.001352183986455202, 0.01590609736740589, 0.0491485670208931, -0.20522835850715637, -0.19656091928482056, -0.002545323222875595, -0.05657441169023514, -0.03616444766521454, 0.0043666549026966095, -0.12251225113868713, -0.024337083101272583, 0.10043641924858093, 0.04612858220934868, 0.06691741943359375, -0.10277292877435684, 0.09654240310192108, -0.0485338419675827, 0.05864226073026657, -0.03048011288046837, 0.08270448446273804, -0.0004058973863720894, 0.018792562186717987, -0.008010143414139748, 0.12106826156377792, 0.06298547983169556, 0.10201112926006317, 0.05624432861804962, 0.03637389466166496, 0.06847748160362244, 0.07385492324829102, 0.08061705529689789, 0.18792235851287842, -0.0284217931330204, 0.08540745079517365, -0.21601687371730804, 0.10012852400541306, -0.068507120013237, 0.06873640418052673, 0.0827953964471817, 0.1550639420747757, 0.03587218001484871, 0.13360890746116638, 0.057194314897060394, 0.10186873376369476, -0.12826476991176605, 0.027279376983642578, -0.015782220289111137, -0.16123612225055695, 0.017344292253255844, 0.03046010434627533, -0.022285854443907738, 0.04249144345521927, -0.037863053381443024, -0.0075193787924945354, -0.019849883392453194, -0.010198298841714859, -0.10920476913452148, 0.04808734357357025, 0.017175104469060898, 0.01614988036453724, -0.03460174798965454, 0.056411512196063995, 0.05684443935751915, -0.0482938326895237, 0.0927221029996872, -0.03274105489253998, -0.00048819370567798615, -0.06764025241136551, 0.14668110013008118, 0.0006273780018091202, -0.035676583647727966, 0.16040152311325073, 0.07756878435611725, 0.06096673756837845, -0.10118334740400314, -0.04208590090274811, -0.11907230317592621, -0.0007503442466259003, -0.006315926555544138, -0.18566840887069702, 9.54286297401497e-33, -0.07326233386993408, 0.14899751543998718, 0.09425938129425049, 0.04836159944534302, -0.09059105813503265, -0.11122926324605942, 0.018085313960909843, 0.09641725569963455, -0.21351253986358643, -0.12437045574188232, -0.09949249029159546, -0.01905965805053711, 0.014453239738941193, 0.22186866402626038, -0.02250937931239605, -0.1273825615644455, -0.18835245072841644, -0.07201486080884933, -0.14675948023796082, -0.08531535416841507, -0.05053531751036644, 0.0057792202569544315, 0.00675618089735508, 0.0955565869808197, 0.005095569416880608, -0.08093591034412384, -0.0026723993942141533, -0.005915980786085129, 0.16286762058734894, 0.05965546518564224, -0.14266923069953918, 0.12270447611808777, 0.06127367168664932, -0.02323343977332115, 0.008305070921778679, 0.0052682384848594666, 0.00814242847263813, -0.14317643642425537, -0.01138522569090128, 0.19909018278121948, 0.07128648459911346, 0.1002105176448822, -0.13244476914405823, -0.140777587890625, 0.10110865533351898, 0.0003523780032992363, -0.013541394844651222, 0.07205656170845032, -0.19691480696201324, -0.0019595064222812653, 0.0027376622892916203, 0.07708156853914261, -0.05096738412976265, 0.007538158446550369, 0.02527892030775547, -0.03158193826675415, -0.1272394061088562, -0.15451818704605103, 0.10140959173440933, 0.10435838997364044, 0.035611458122730255, 0.08698831498622894, 0.007842501625418663, 0.11217048019170761, -0.17750202119350433, 0.15873299539089203, 0.14792615175247192, -0.010287891142070293, -0.04863454028964043, 0.20347246527671814, 0.0592050701379776, -0.06006944179534912, 0.05546949803829193, -0.12749356031417847, 0.049776751548051834, -0.044967878609895706, 0.12390300631523132, 0.06124580651521683, 0.05764903500676155, 0.006834225729107857, 0.17177051305770874, 0.07967740297317505, -0.12008431553840637, 0.12103594839572906, 0.03221495449542999, -0.13185462355613708, -0.08784277737140656, 0.04966844990849495, -0.10775189101696014, -0.03583235666155815, 0.0970313623547554, -0.09456832706928253, 0.08265675604343414, -0.014159588143229485, -0.0387033075094223, -8.154172151519921e-33, -0.06247854232788086, -0.13106611371040344, 0.018858997151255608, 0.10719755291938782, -0.06006179377436638, 0.021339794620871544, 0.037759073078632355, -0.14631792902946472, 0.1375942826271057, -0.14493055641651154, -0.0120053980499506, 0.07325801253318787, 0.07630248367786407, -0.002457731869071722, -0.018632350489497185, -0.000956307165324688, -0.011486910283565521, -0.1390148103237152, -0.15728414058685303, -0.06449054181575775, 0.09692640602588654, 0.13020887970924377, -0.04246866703033447, 0.07817603647708893, -0.007423152681440115, 0.07036985456943512, -0.05605420097708702, 0.10412758588790894, 0.20490092039108276, -0.0076993536204099655, -0.09518985450267792, -0.03006092458963394, -0.14441007375717163, 0.07082866877317429, -0.02195122092962265, 0.0331730917096138, 0.15357503294944763, -0.16322171688079834, 0.06380397081375122, -0.11526214331388474, 0.13538801670074463, 0.020687296986579895, -0.1762908697128296, 0.02233937568962574, 0.03412466123700142, 0.11776326596736908, -0.0027003102004528046, 0.12007366865873337, 0.23979789018630981, 0.0764395147562027, 0.11107417196035385, -0.010823938995599747, -0.06528758257627487, -0.07906720042228699, -0.0675889179110527, 0.0016629304736852646, 0.01633135974407196, -0.11609034240245819, -0.025719866156578064, 0.1368037760257721, -0.05746478587388992, 0.07621528208255768, 0.005902459379285574, 0.056670233607292175, -0.0020306147634983063, 0.05855584517121315, 0.13433760404586792, 0.03467205911874771, -0.048728443682193756, -0.24995307624340057, 0.020975664258003235, 0.0002726716920733452, 0.09401556849479675, -0.057427771389484406, -0.0016009015962481499, 0.14660948514938354, -0.06569425761699677, -0.08144360780715942, -0.09985683858394623, 0.11505734920501709, 0.05535978078842163, -0.11514700949192047, 0.1386522650718689, -0.128217875957489, 0.09086926281452179, 0.10730676352977753, -0.07004307210445404, -0.06230727583169937, -0.07144336402416229, 0.006186625454574823, -0.15617606043815613, -0.07592616975307465, 0.022521406412124634, 0.1542169600725174, 0.01809774711728096, -9.999887140565988e-08, 0.27533137798309326, -0.08497214317321777, 0.006425928324460983, -0.17679977416992188, 0.02889961004257202, -0.0075448378920555115, -0.06688806414604187, 0.08619923144578934, 0.007252099458128214, 0.16224758327007294, 0.07994364202022552, 0.14789584279060364, -0.21328294277191162, 0.17031565308570862, -0.009993193671107292, 0.06955035030841827, -0.13930103182792664, -0.00801190733909607, -0.07778514921665192, 0.04408373683691025, -0.06194585934281349, 0.12072986364364624, 0.02605282887816429, -0.05619416385889053, 0.042036280035972595, -0.058941006660461426, -0.02653948962688446, 0.08056439459323883, 0.04097875952720642, -0.04225311428308487, -0.042616501450538635, -0.15223458409309387, 0.15415045619010925, 0.10143400728702545, -0.06793955713510513, -0.1637062132358551, 0.0848192572593689, 0.10776351392269135, -0.012568740174174309, 0.17188268899917603, 0.11826011538505554, 0.007119736634194851, -0.12266716361045837, 0.006994316354393959, -0.14313146471977234, -0.12452031672000885, -0.11245997250080109, -0.007867390289902687, 0.0022224923595786095, 0.007327985018491745, -0.06146299093961716, 0.08783680200576782, -0.05389806628227234, -0.06232766807079315, -0.021762285381555557, 0.17754986882209778, -0.12882842123508453, -0.07076762616634369, -0.11093752086162567, -0.07232694327831268, 0.05695159360766411, -0.29162806272506714, 0.14575830101966858, 0.11773397028446198], "changes": {"1wk": 16.770185001709283, "1mo": -16.770185001709283}}, {"text": "Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer Caribou Biosciences, Inc. Thu, Jan 2, 2025, 4:00 PM 5 min read In This Article: CRBU -4.20% Caribou Biosciences, Inc. BERKELEY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the appointment of Sri Ryali as chief financial officer, effective immediately. Mr. Ryali brings 20 years of finance and commercial experience in the biopharmaceutical industry to his role, and he will be responsible for the strategic leadership of the corporate finance, investor relations, and corporate communications functions. He will report to Rachel Haurwitz, PhD, Caribou\u2019s president and chief executive officer. \u201cI am excited to welcome Sri to Caribou at the beginning of this pivotal year for our organization as we advance four clinical-stage programs for hematologic malignancies and autoimmune diseases and plan to disclose multiple datasets in 2025,\u201d said Dr. Haurwitz. \u201cSri\u2019s leadership experience at biopharmaceutical companies across all stages of drug development and commercialization will be valuable as we execute on our plans and prepare for the next steps for our programs.\u201d Most recently, Mr. Ryali served as the chief financial officer of Codexis, Inc., a publicly traded enzyme engineering company. Previously, he served as chief financial officer of Eiger BioPharmaceuticals, Inc., then a publicly traded, commercial-stage company. Previously at Aimmune Therapeutics, Inc., Mr. Ryali held roles of increasing responsibility, most recently as vice president of finance. Earlier in his career, he worked at Onyx Pharmaceuticals, Inc. and Amgen Inc. in finance-related positions of increasing responsibility. Mr. Ryali earned an MBA from the UCLA Anderson School of Management and a BA from the University of California, Los Angeles, with a double major in economics and microbiology, immunology, and molecular genetics. \u201cCaribou\u2019s leadership in developing CRISPR genome-edited cell therapies and the current momentum across the pipeline continue to stand out in the biotech landscape,\u201d said Mr. Ryali. \u201cI look forward to working closely with teams across this mission-driven organization as we focus on delivering off-the-shelf CAR-T cell therapies to patients with devastating diseases who need readily available and more broadly accessible treatment options.\u201d A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8d7c3f3b-b81a-4d70-81b9-76bd2fe84c9f Sri-Ryali-CFO About Caribou\u2019s novel next-generation CRISPR platform CRISPR genome editing uses easily designed, modular biological tools to make DNA changes in living cells. There are two basic components of Class 2 CRISPR systems: the nuclease protein that cuts DNA and the RNA molecule(s) that guide the nuclease to generate a site-specific, double-stranded break, leading to an edit at the targeted genomic site. CRISPR systems are capable of editing unintended genomic sites, known as off-target editing, which may lead to harmful effects on cellular function and phenotype. In response to this challenge, Caribou has developed CRISPR hybrid RNA-DNA guides (chRDNAs; pronounced \u201cchardonnays\u201d) that direct substantially more precise genome editing compared to all-RNA guides. Caribou is deploying the power of its Cas12a chRDNA technology to carry out high efficiency multiple edits, including multiplex gene insertions, to develop CRISPR-edited therapies. Story Continues About Caribou Biosciences, Inc. Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company\u2019s genome-editing platform, including its Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve activity against disease. Caribou is advancing a pipeline of off-the-shelf cell therapies from its CAR-T platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases. Follow us @CaribouBio and visit www.cariboubio.com . Forward-looking statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terms such as \u201cmay,\u201d \u201cwill,\u201d \u201cshould,\u201d \u201cexpect,\u201d \u201cplan,\u201d \u201canticipate,\u201d \u201ccould,\u201d \u201cintend,\u201d \u201ctarget,\u201d \u201cproject,\u201d \u201ccontemplate,\u201d \u201cbelieve,\u201d \u201cestimate,\u201d \u201cpredict,\u201d \u201cpotential,\u201d or \u201ccontinue,\u201d or the negative of these terms or other similar expressions, although not all forward-looking statements contain these words. These forward-looking statements include, without limitation, statements related to Caribou\u2019s strategy, plans, and objectives, and expectations regarding its clinical and preclinical development programs. Management believes that these forward-looking statements are reasonable as and when made. However, such forward-looking statements are subject to risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include, without limitation, risks inherent in the development of cell therapy products; uncertainties related to the initiation, cost, timing, progress, and results of Caribou\u2019s current and future research and development programs, preclinical studies, and clinical trials; and the risk that initial, preliminary, or interim clinical trial data will not ultimately be predictive of the safety and efficacy of Caribou\u2019s product candidates or that clinical outcomes may differ as patient enrollment continues and as more patient data becomes available; the risk that preclinical study results observed will not be borne out in human patients or different conclusions or considerations are reached once additional data have been received and fully evaluated; the ability to obtain key regulatory input and approvals; as well as other risk factors described from time to time in Caribou\u2019s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent filings. In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. Except as required by law, Caribou undertakes no obligation to update publicly any forward-looking statements for any reason. Caribou Biosciences, Inc. Contacts: Investors: Amy Figueroa, CFA investor.relations@cariboubio.com Media: Peggy Vorwald, PhD media@cariboubio.com View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CRBU", "date": "2025-01-02T13:00:00+00:00", "sentiment": {"score": 0.11746471654623747, "confidence": 0.12774896621704102, "probabilities": {"positive": 0.12774896621704102, "negative": 0.010284249670803547, "neutral": 0.8619667887687683}}, "embedding": [-0.08468161523342133, -0.11055683344602585, -0.11716392636299133, -0.09848946332931519, -0.0206342451274395, 0.006222499534487724, -0.0028677613008767366, 0.1380375176668167, 0.04613211750984192, 0.11656007170677185, -0.15681560337543488, -0.010262919589877129, -0.041179027408361435, 0.07695189863443375, -0.12274082005023956, -0.04996167868375778, -0.1347598284482956, 0.04215927794575691, -0.09951336681842804, 0.022888749837875366, -0.03716301918029785, 0.002405703067779541, 0.07500255107879639, -0.008274650201201439, 0.029717624187469482, -0.050229743123054504, -0.0409458763897419, -0.027859162539243698, -0.24597257375717163, -0.09816226363182068, 0.12725147604942322, 0.035129573196172714, 0.12150342762470245, -0.0996822863817215, 0.06828393042087555, 0.07517938315868378, -0.10525701940059662, 0.02599819377064705, 0.015447667799890041, -0.06652679294347763, 0.008849992416799068, -0.10324336588382721, -0.13873323798179626, 0.02928977832198143, -0.051024179905653, -0.16300038993358612, 0.08633438497781754, -0.015519662760198116, -0.0021155010908842087, -0.008238100446760654, -0.2799094319343567, -0.09028904139995575, -0.02992735430598259, -0.020816093310713768, -0.036969199776649475, 0.11713141202926636, 0.017130061984062195, -0.09981431066989899, 0.031422678381204605, -0.057155266404151917, -0.025741958990693092, -0.0551559254527092, 0.019662994891405106, 0.05039073899388313, 0.04329874366521835, -0.034624356776475906, 0.051439471542835236, -0.029800016433000565, -0.029110196977853775, -0.0011926069855690002, 0.07900600135326385, -0.07394037395715714, -0.04922737926244736, 0.050596341490745544, -0.017079591751098633, 0.16353538632392883, 0.07564621418714523, 0.22405630350112915, 0.1782252937555313, -0.13126026093959808, 0.1378450095653534, -0.03274627774953842, 0.03073892742395401, -0.016020795330405235, -0.056740790605545044, 0.0649542361497879, 0.10338188707828522, 0.03576008230447769, 0.06171815097332001, 0.06092262268066406, 0.17447969317436218, -0.03102795034646988, 0.1093035638332367, -0.05434582009911537, -0.16081179678440094, 0.002297027036547661, 0.04991669952869415, -0.045722056180238724, 0.08909409493207932, -0.000992999179288745, -0.05781660974025726, 0.01769869774580002, -0.06804003566503525, -0.01855730265378952, -0.11942485719919205, -0.03821413964033127, -0.051197074353694916, -0.019180595874786377, 0.06370177865028381, 0.000839160056784749, -0.10031218081712723, 0.14121675491333008, -0.08674873411655426, -0.0025659038219600916, -0.13191652297973633, 0.11936934292316437, -0.09823282808065414, 0.048641569912433624, 0.14482466876506805, 0.05177623778581619, 0.03183767572045326, 0.06501452624797821, -0.04630732536315918, -0.047342412173748016, 0.07476656138896942, 0.048736054450273514, -0.1651843935251236, 8.980973735586039e-33, 0.0604519359767437, 0.0635339766740799, 0.06498295813798904, -0.007937317714095116, -0.019832566380500793, 0.0345919132232666, -0.026750167831778526, -0.013935120776295662, -0.09329398721456528, -0.10189318656921387, -0.08543436229228973, -0.012639373540878296, 0.007532190531492233, 0.0713055431842804, -0.11314760148525238, -0.0011441670358181, -0.1184968426823616, -0.009569002315402031, -0.09894777834415436, -0.01345121581107378, -0.03295242041349411, 0.06257438659667969, -0.07314039766788483, 0.10818301141262054, 0.046465709805488586, 0.05223667621612549, -0.04580080509185791, 0.03132152929902077, 0.07421108335256577, 0.09889529645442963, -0.004804479423910379, -0.016237054020166397, -0.08067134022712708, -0.05839509516954422, 0.08074694126844406, -0.07705814391374588, -0.11001832783222198, -0.08175257593393326, 0.07318143546581268, 0.1540028601884842, 0.021647591143846512, 0.06893771886825562, -0.11024059355258942, -0.05615590512752533, 0.00031379819847643375, -0.06636427342891693, 0.08004835247993469, 0.1506597399711609, 0.09040912240743637, -0.004370442591607571, -0.06976132839918137, -0.0820164903998375, 0.08681440353393555, -0.099722720682621, 0.05788438022136688, 0.00996626541018486, -0.09373722970485687, -0.09512713551521301, 0.0426325649023056, 0.054949332028627396, -0.026406534016132355, 0.11602191627025604, -0.07194069772958755, 0.06388777494430542, -0.07160460948944092, 0.04025024548172951, -0.011659098789095879, -0.09536657482385635, 0.15547412633895874, 0.06656643003225327, 0.003846742445603013, -0.07501029968261719, 0.16535542905330658, 0.04661813750863075, -0.013003225438296795, -0.028255371376872063, 0.07214586436748505, 0.07951314747333527, -0.06135627627372742, 0.044513143599033356, 0.029750056564807892, 0.1164737194776535, -0.02404782548546791, 0.028898803517222404, 0.07025597989559174, -0.0620693564414978, -0.04368111118674278, -0.05415615811944008, -0.08236023783683777, 0.06512293964624405, 0.0481075756251812, -0.09816890954971313, 0.007285826839506626, 0.09899391233921051, -0.07422184944152832, -1.0297813200571045e-32, -0.009824590757489204, -0.04578756168484688, 0.02591358870267868, -0.014258816838264465, -0.0488002747297287, 0.06663593649864197, 0.0494762621819973, -0.08263756334781647, 0.13834404945373535, -0.1706095039844513, 0.08082973212003708, 0.10304072499275208, 0.03183447942137718, -0.07204710692167282, -0.03849884122610092, 0.029009291902184486, 0.06340906769037247, -0.08107385039329529, -0.21149516105651855, 0.027016259729862213, -0.021964572370052338, 0.08336813002824783, -0.02242092788219452, 0.09075421094894409, 0.08709435164928436, 0.04504409432411194, 0.04070298373699188, 0.13012711703777313, 0.05226035416126251, -0.03520754724740982, -0.016248341649770737, 0.023934297263622284, -0.2669614553451538, 0.038703806698322296, -0.039007727056741714, -0.022113356739282608, 0.03931398689746857, -0.09409397840499878, 0.012248586863279343, 0.06692944467067719, 0.19477826356887817, 0.04388052970170975, -0.033600520342588425, -0.0005228295922279358, -0.004484277218580246, -0.02561546489596367, -3.1938252504915e-06, 0.05503975227475166, 0.07636241614818573, 0.013838808983564377, -0.09542079269886017, 0.05031835660338402, -0.07118681073188782, -0.020809752866625786, -0.020402532070875168, 0.023667631670832634, 0.11486096680164337, -0.042604852467775345, -0.05872393399477005, 0.03338756784796715, 0.056766144931316376, 0.14529450237751007, 0.10423800349235535, 0.02849220111966133, 0.026464994996786118, 0.09534800797700882, 0.06327389180660248, -0.08513365685939789, 0.02069379948079586, -0.1481650471687317, -0.009545236825942993, -0.13230781257152557, 0.04004238545894623, -0.08821320533752441, -0.00250349217094481, 0.114938884973526, -0.23964156210422516, -0.1320997178554535, -0.1324022114276886, 0.015646500512957573, 0.07368167489767075, -0.07715554535388947, -0.02364901825785637, 7.809977978467941e-05, 0.031160051003098488, 0.035424597561359406, -0.04525010660290718, -0.099821537733078, 0.0235944464802742, -0.02832154929637909, -0.06581184267997742, -0.16070833802223206, -0.03499584645032883, 0.14898255467414856, 0.10147997736930847, -1.0086588986268907e-07, 0.21244288980960846, -0.09577807784080505, -0.014136753976345062, -0.08016158640384674, 0.0779813826084137, -0.018636532127857208, -0.1125498116016388, -0.029923969879746437, 0.059308864176273346, 0.15597330033779144, 0.06800355017185211, 0.17191490530967712, -0.11902390420436859, 0.040197085589170456, 0.017105398699641228, 0.08879561722278595, -0.02497057616710663, 0.020598985254764557, -0.12448175251483917, 0.05302131175994873, -0.046623654663562775, 0.10298444330692291, -0.10076507925987244, -0.006275899708271027, 0.1482734978199005, -0.14762625098228455, -0.004091125912964344, 0.035016633570194244, -0.017728611826896667, -0.00903085432946682, 0.055131517350673676, -0.004114154726266861, 0.0494798943400383, 0.052906617522239685, -0.04942238703370094, -0.1531686782836914, 0.10467659682035446, 0.02867932617664337, 0.009626062586903572, 0.100470170378685, 0.04181424528360367, 0.08232258260250092, -0.05039655789732933, 0.06531142443418503, -0.10544854402542114, -0.0326867550611496, -0.12221679091453552, 0.0606544204056263, -0.015727028250694275, -0.12211787700653076, -0.04736226052045822, 0.05863603577017784, -0.05303509160876274, -0.01558883860707283, -0.05493730306625366, 0.11810147762298584, -0.04234575480222702, -0.06696964800357819, -0.09088817983865738, -0.09728182852268219, -0.01603665202856064, -0.1265449821949005, 0.17555969953536987, -0.0447695292532444], "changes": {"1wk": 2.3809572804273027, "1mo": -14.880952845557763}}, {"text": "Caribou Biosciences (CRBU) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now Zacks Equity Research Mon, Dec 16, 2024, 5:55 PM 3 min read In This Article: CRBU -4.20% The price trend for Caribou Biosciences, Inc. (CRBU) has been bearish lately and the stock has lost 10.3% over the past week. However, the formation of a hammer chart pattern in its last trading session indicates that the stock could witness a trend reversal soon, as bulls might have gained significant control over the price to help it find support. The formation of a hammer pattern is considered a technical indication of nearing a bottom with likely subsiding of selling pressure. But this is not the only factor that makes a bullish case for the stock. On the fundamental side, strong agreement among Wall Street analysts in raising earnings estimates for this company enhances its prospects of a trend reversal. 1-month candlestick chart for CRBU What is a Hammer Chart and How to Trade It? This is one of the popular price patterns in candlestick charting. A minor difference between the opening and closing prices forms a small candle body, and a higher difference between the low of the day and the open or close forms a long lower wick (or vertical line). The length of the lower wick being at least twice the length of the real body, the candle resembles a 'hammer.' In simple terms, during a downtrend, with bears having absolute control, a stock usually opens lower compared to the previous day's close, and again closes lower. On the day the hammer pattern is formed, maintaining the downtrend, the stock makes a new low. However, after eventually finding support at the low of the day, some amount of buying interest emerges, pushing the stock up to close the session near or slightly above its opening price. When it occurs at the bottom of a downtrend, this pattern signals that the bears might have lost control over the price. And, the success of bulls in stopping the price from falling further indicates a potential trend reversal. Hammer candles can occur on any timeframe -- such as one-minute, daily, weekly -- and are utilized by both short-term as well as long-term investors. Like every technical indicator, the hammer chart pattern has its limitations. Particularly, as the strength of a hammer depends on its placement on the chart, it should always be used in conjunction with other bullish indicators. Here's What Makes the Trend Reversal More Likely for CRBU An upward trend in earnings estimate revisions that CRBU has been witnessing lately can certainly be considered a bullish indicator on the fundamental side. That's because empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. Story Continues The consensus EPS estimate for the current year has increased 1.4% over the last 30 days. This means that the Wall Street analysts covering CRBU are majorly in agreement about the company's potential to report better earnings than what they predicted earlier. If this is not enough, you should note that CRBU currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. And stocks carrying a Zacks Rank #1 or 2 usually outperform the market. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Moreover, the Zacks Rank has proven to be an excellent timing indicator, helping investors identify precisely when a company's prospects are beginning to improve. So, for the shares of Caribou Biosciences, a Zacks Rank of 2 is a more conclusive fundamental indication of a potential turnaround. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Caribou Biosciences, Inc. (CRBU) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CRBU", "date": "2024-12-16T14:55:07+00:00", "sentiment": {"score": -0.43899836763739586, "confidence": 0.49455299973487854, "probabilities": {"positive": 0.05555463209748268, "negative": 0.49455299973487854, "neutral": 0.4498922824859619}}, "embedding": [-0.06357406824827194, -0.03086322732269764, 0.07817870378494263, 0.0557439923286438, -0.018769551068544388, 0.02691545896232128, -0.06032457575201988, 0.1516922414302826, 0.08687739074230194, 0.05283719301223755, -0.07987317442893982, 0.036485932767391205, -0.021158268675208092, -0.05370451509952545, -0.037817202508449554, -0.018044160678982735, -0.1164332926273346, -0.1749565601348877, -0.04802044853568077, 0.0653311237692833, -0.05187953636050224, -0.13002559542655945, -0.11107978969812393, 0.035876739770174026, -0.04095043987035751, 0.01674899272620678, -0.0870952308177948, 0.07661421597003937, 0.061299245804548264, -0.01328788697719574, 0.05469910055398941, 0.13590680062770844, -0.0009125778451561928, -0.005210379604250193, -0.11943972110748291, -0.003592623397707939, 0.011616671457886696, 0.0683329701423645, 0.07490278780460358, 0.08554668724536896, -0.00036378251388669014, 0.01599922589957714, -0.1389467865228653, 0.0016393510159105062, -0.001581626245751977, 0.01952838897705078, -0.026710201054811478, 0.026535920798778534, -0.05636315047740936, -0.010528955608606339, -0.12039676308631897, -0.09621842205524445, -0.05248741805553436, 0.13166433572769165, 0.06319481134414673, 0.09172110259532928, -0.015809286385774612, -0.027326764538884163, 0.24325302243232727, -0.0152828898280859, 0.04517342522740364, 0.10241583734750748, -0.043861955404281616, -0.011063242331147194, 0.24145719408988953, -0.03767942637205124, -0.05465404689311981, -0.017044633626937866, 0.058531809598207474, 0.16272523999214172, 0.12171956151723862, -0.04940268397331238, -0.10038147866725922, -0.07611127197742462, 0.015965133905410767, 0.052860014140605927, 0.016754239797592163, -0.03636861592531204, 0.02094987966120243, -0.0636884793639183, -0.1554296612739563, -0.018611665815114975, -0.02122199535369873, -0.11127439141273499, 0.013571877963840961, -0.03030312806367874, 0.1370278298854828, -0.08891168236732483, 0.03474704921245575, 0.08784784376621246, 0.07766705006361008, -0.08794866502285004, -0.10666678100824356, 0.020831309258937836, 0.019088201224803925, 0.03363414481282234, 0.0409499928355217, 0.07388289272785187, 0.06233729422092438, 0.0731332078576088, 0.060506418347358704, 0.0641486793756485, -0.0485377237200737, -0.07630689442157745, 0.01843639463186264, -0.13637682795524597, -0.11125646531581879, 0.042795635759830475, -0.03972255811095238, 0.04584420844912529, -0.10540443658828735, 0.10540438443422318, -0.00833561085164547, -0.05676209181547165, -0.09453721344470978, 0.018171127885580063, -0.13703882694244385, -0.026663251221179962, -0.020676547661423683, -0.010222645476460457, 0.1752403974533081, 0.01672445237636566, -0.08912564069032669, -0.14867006242275238, -0.025711819529533386, 0.05286930501461029, -0.17313933372497559, 4.911754655768957e-33, 0.00040652044117450714, -0.00408506765961647, -0.08486154675483704, -0.1261867880821228, -0.10709890723228455, 0.010725129395723343, -0.20068694651126862, 0.049863897264003754, 0.023457180708646774, 0.12373409420251846, 0.03356042131781578, 0.255513459444046, 0.04426427185535431, 0.03293542191386223, -0.0721176415681839, -0.07025045901536942, -0.04763934016227722, -0.04617795720696449, -0.02729215659201145, -0.08316411077976227, -0.10200896859169006, -0.031216561794281006, -0.043322186917066574, -0.024767637252807617, -0.06414134800434113, 0.01979348063468933, 0.08786939084529877, 0.047013748437166214, -0.13164730370044708, 0.06911446899175644, 0.10045235604047775, 0.06875412166118622, -0.052135445177555084, -0.12092234939336777, 0.02880037948489189, -0.08599041402339935, 0.020127996802330017, -0.15055277943611145, -0.06894955784082413, -0.03908715769648552, -0.03805054351687431, -0.03058180771768093, -0.18529531359672546, -0.0995817631483078, 0.1188095286488533, 0.0025136866606771946, 0.007437469903379679, -0.05197933316230774, -0.08104775100946426, -0.004989175125956535, -0.057164113968610764, 0.07605473697185516, 0.10683062672615051, -0.01906657963991165, -0.03798900544643402, 0.07508327811956406, 0.014385302551090717, -0.17877323925495148, -0.05542710795998573, 0.034601062536239624, 0.0651974081993103, 0.09224988520145416, 0.11954435706138611, -0.041479162871837616, -0.13079100847244263, 0.07286135107278824, -0.06520054489374161, 0.058144792914390564, -0.056423477828502655, 0.07884257286787033, 0.05694377422332764, 0.03913862258195877, 0.046757906675338745, -0.10510025918483734, 0.08864090591669083, -0.04730089008808136, 0.0722445696592331, 0.14416511356830597, -0.06344792246818542, -0.002246430143713951, -0.05107885226607323, -0.07183851301670074, 0.15537436306476593, 0.009781301021575928, 0.00012655742466449738, -0.13501401245594025, -0.00848354585468769, -0.1080327033996582, -0.16895827651023865, -0.06261492520570755, -0.055397432297468185, -0.03330567479133606, -0.03256690874695778, 0.1354076862335205, -0.010738162323832512, -6.302191087374977e-33, -0.07923351228237152, -0.03242502361536026, -0.06396503746509552, 0.09967610985040665, 0.05052688345313072, 0.0835932046175003, 0.08786436170339584, -0.03926893323659897, -0.036104463040828705, -0.024151451885700226, 0.02854018285870552, 0.042924001812934875, -0.1501951366662979, 0.011579747311770916, 0.06090540438890457, 0.024037474766373634, 0.037045903503894806, 0.020239369943737984, -0.03368791937828064, -0.04456844925880432, 0.07311971485614777, 0.20388633012771606, -0.18408943712711334, 0.06281407177448273, 0.02616853453218937, 0.07483279705047607, -0.0049851518124341965, 0.05072896182537079, -0.03908843547105789, -0.027992364019155502, -0.01695844531059265, -0.05001267418265343, -0.06170225515961647, -0.02210991457104683, -0.12901781499385834, 0.07785483449697495, 0.07576562464237213, -0.10262132436037064, -0.004781716037541628, 0.10097987949848175, 0.1738017499446869, 0.10069264471530914, 0.1465163379907608, -0.14554937183856964, -0.017848901450634003, 0.01276321243494749, 0.03532964736223221, 0.08497771620750427, 0.1717691868543625, 0.16854539513587952, 0.19064921140670776, 0.10994041711091995, -0.05196704715490341, 0.07444517314434052, -0.11046897619962692, 0.07959575951099396, -0.022079816088080406, 0.013793062418699265, -0.1170593798160553, 0.17798294126987457, 0.016042154282331467, 0.07406031340360641, 0.09491515159606934, -0.015827681869268417, -0.0019573643803596497, -0.052044160664081573, 0.03517456725239754, -0.1531718224287033, 0.06519786268472672, -0.10069745779037476, 0.04038769006729126, 0.06218356639146805, 0.08165326714515686, -0.02381214313209057, 0.013427277095615864, 0.11441560089588165, -0.04949373006820679, -0.1399426907300949, -0.06437890231609344, 0.038163281977176666, -0.10149149596691132, 0.009911744855344296, 0.11440016329288483, 0.18396827578544617, -0.14886197447776794, 0.035188958048820496, -0.2997305989265442, 0.03115014173090458, -0.03421972692012787, -0.03485909104347229, -0.007657471112906933, -0.06010700762271881, -0.09974472224712372, -0.015420593321323395, 0.09091081470251083, -9.95633655520578e-08, -0.002845976036041975, -0.07314495742321014, 0.0894375592470169, 0.019774839282035828, 0.1395379602909088, 0.016123129054903984, 0.08250201493501663, 0.0021652979776263237, -0.058555494993925095, 0.06989146023988724, 0.16617751121520996, 0.02468888647854328, -0.1010231077671051, 0.031243307515978813, -0.08266602456569672, 0.06771955639123917, -0.07183092087507248, -0.06988631188869476, -0.07776843756437302, -0.07554323226213455, 0.050973281264305115, -0.06889156997203827, 0.11385539174079895, 0.09345261752605438, 0.03737736493349075, -0.14781570434570312, -0.0017643887549638748, 0.1631767898797989, -0.09564768522977829, 0.04832785576581955, 0.0042712874710559845, 0.050750166177749634, 0.07509444653987885, -0.10122007131576538, 0.025402959436178207, 0.13698169589042664, -0.016704507172107697, 0.028876883909106255, -0.08636936545372009, 0.1678307056427002, -0.002674131654202938, -0.02486131526529789, -0.021709203720092773, 0.012741508893668652, 0.0003256872296333313, -0.03416246175765991, -0.035185761749744415, 0.13919946551322937, 0.02157106250524521, -0.06751170009374619, 0.054710447788238525, -0.0023706648498773575, 0.06796277314424515, 0.0036193113774061203, 0.06091759353876114, 0.05744965374469757, -0.057901062071323395, -0.0892205759882927, 0.008601422421634197, -0.00026402436196804047, 0.09380798041820526, -0.1381140947341919, -0.01467004232108593, 0.029159385710954666], "changes": {"1wk": -6.282722872536994, "1mo": -17.80104293775134}}, {"text": "Here's Why Caribou Biosciences (NASDAQ:CRBU) Must Use Its Cash Wisely editorial-team@simplywallst.com (Simply Wall St) Mon, Dec 23, 2024, 4:59 PM 3 min read In This Article: CRBU -4.20% We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com? So, the natural question for Caribou Biosciences ( NASDAQ:CRBU ) shareholders is whether they should be concerned by its rate of cash burn. For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth (also called its negative free cash flow). We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway. View our latest analysis for Caribou Biosciences How Long Is Caribou Biosciences' Cash Runway? You can calculate a company's cash runway by dividing the amount of cash it has by the rate at which it is spending that cash. As at September 2024, Caribou Biosciences had cash of US$228m and no debt. Importantly, its cash burn was US$132m over the trailing twelve months. Therefore, from September 2024 it had roughly 21 months of cash runway. While that cash runway isn't too concerning, sensible holders would be peering into the distance, and considering what happens if the company runs out of cash. You can see how its cash balance has changed over time in the image below. NasdaqGS:CRBU Debt to Equity History December 23rd 2024 How Well Is Caribou Biosciences Growing? At first glance it's a bit worrying to see that Caribou Biosciences actually boosted its cash burn by 22%, year on year. It's even more troubling to see that operating revenue fell 67% during the period. In light of the above-mentioned, we're pretty wary of the trajectory the company seems to be on. Clearly, however, the crucial factor is whether the company will grow its business going forward. So you might want to take a peek at how much the company is expected to grow in the next few years . How Hard Would It Be For Caribou Biosciences To Raise More Cash For Growth? Since Caribou Biosciences can't yet boast improving growth metrics, the market will likely be considering how it can raise more cash if need be. Issuing new shares, or taking on debt, are the most common ways for a listed company to raise more money for its business. One of the main advantages held by publicly listed companies is that they can sell shares to investors to raise cash and fund growth. We can compare a company's cash burn to its market capitalisation to get a sense for how many new shares a company would have to issue to fund one year's operations. Story Continues Caribou Biosciences' cash burn of US$132m is about 81% of its US$163m market capitalisation. That suggests the company may have some funding difficulties, and we'd be very wary of the stock. How Risky Is Caribou Biosciences' Cash Burn Situation? Even though its cash burn relative to its market cap makes us a little nervous, we are compelled to mention that we thought Caribou Biosciences' cash runway was relatively promising. After looking at that range of measures, we think shareholders should be extremely attentive to how the company is using its cash, as the cash burn makes us uncomfortable. Taking a deeper dive, we've spotted 4 warning signs for Caribou Biosciences you should be aware of, and 1 of them is concerning. Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies, and this list of stocks growth stocks (according to analyst forecasts) Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CRBU", "date": "2024-12-23T13:59:01+00:00", "sentiment": {"score": -0.10001258552074432, "confidence": 0.20506899058818817, "probabilities": {"positive": 0.10505640506744385, "negative": 0.20506899058818817, "neutral": 0.6898745894432068}}, "embedding": [0.02625708281993866, -0.053001247346401215, -0.002410718472674489, -0.05170243978500366, 0.04791969060897827, -0.008886910043656826, 0.021351607516407967, 0.08827396482229233, 0.04414667934179306, 0.12284627556800842, -0.04868044704198837, -0.05877571552991867, -0.05415050685405731, -0.02320796065032482, -0.12423782050609589, -0.0671783909201622, -0.11708667129278183, -0.11593122780323029, 0.0016850456595420837, 0.12705418467521667, -0.039842817932367325, -0.03845774382352829, -0.03824152052402496, 0.09642621129751205, 0.039582766592502594, 0.0009973932756111026, -0.1179390400648117, 0.015486404299736023, -0.1484445333480835, -0.011682750657200813, 0.08786715567111969, 0.2377774715423584, 0.13340429961681366, -0.03226997330784798, 0.012139897793531418, 0.04434520751237869, -0.01972537860274315, 0.04355785250663757, 0.005816899240016937, 0.08539335429668427, -0.12732186913490295, -0.02968059852719307, -0.0055943941697478294, -0.015266882255673409, -0.027826938778162003, -0.14539995789527893, 0.10517662018537521, 0.02576696127653122, -0.024633212015032768, 0.09018704295158386, -0.05509759113192558, -0.04544256627559662, 0.005907777696847916, 0.04433859512209892, 0.017358683049678802, 0.05147792026400566, -0.005090555176138878, -0.0504954569041729, -0.02678067982196808, -0.06664745509624481, 0.035670652985572815, -0.04014613851904869, 0.05494207516312599, -0.061638474464416504, 0.0944860652089119, -0.01970282383263111, -0.03840935230255127, 0.01750909350812435, -0.04659152403473854, 0.04912743344902992, 0.08615633100271225, -0.07977832108736038, -0.015456992201507092, -0.08879553526639938, -0.10606005042791367, 0.16187715530395508, 0.046218156814575195, 0.15184463560581207, 0.14289841055870056, -0.13457846641540527, 0.0698285698890686, -0.03193436935544014, -0.03343281149864197, -0.12334385514259338, -0.06547044217586517, 0.031447336077690125, 0.16985005140304565, -0.13180193305015564, 0.059488896280527115, 0.08856181800365448, 0.141475111246109, 0.01622050814330578, 0.041045401245355606, -0.02705826796591282, -0.09563130885362625, -0.0024201017804443836, -0.008298395201563835, -0.00823980662971735, 0.08921636641025543, -0.008168349042534828, 0.14146897196769714, 0.18884596228599548, -0.08976206183433533, -0.12683194875717163, 0.013774184510111809, -0.024867229163646698, -0.031239138916134834, 0.0016124788671731949, 0.03547918051481247, 0.02095945179462433, -0.11231088638305664, 0.12530311942100525, -0.11002904176712036, -0.023722967132925987, 0.02394861914217472, 0.05646619200706482, -0.1809600591659546, -0.04168058559298515, 0.051116108894348145, 0.028163256123661995, 0.10457466542720795, 0.15891379117965698, -0.06687244772911072, -0.12221865355968475, 0.0520845465362072, -0.03022836521267891, -0.124327152967453, 1.1893136828157451e-32, 0.004051542840898037, 0.03533623367547989, 0.016983769834041595, -0.06083165854215622, -0.0863550677895546, -0.013737458735704422, -0.11372837424278259, 0.0505545511841774, -0.022011393681168556, -0.018712636083364487, -0.0846470445394516, 0.07265520095825195, 0.048160120844841, -0.062234535813331604, 0.025603128597140312, -0.027915600687265396, -0.1943075954914093, -0.12028896808624268, 0.013841725885868073, -0.03477543964982033, -0.06373162567615509, 0.014033140614628792, -0.037110477685928345, 0.015229188837110996, 0.10041411221027374, -0.06098775193095207, -0.09419864416122437, 0.04665941745042801, -0.018317800015211105, 0.09098349511623383, 0.035712067037820816, 0.026905128732323647, -0.031593531370162964, -0.1264266073703766, 0.00936759915202856, -0.10359528660774231, -0.029963195323944092, -0.0411246120929718, 0.013729434460401535, 0.07789092510938644, 0.014538994990289211, 0.015090285800397396, -0.003264575731009245, -0.09479058533906937, 0.04396255314350128, 0.05645373463630676, 0.07925458997488022, 0.05534197390079498, 0.04558170959353447, 0.02174818515777588, 0.03526223450899124, -0.03888009488582611, 0.04424770176410675, -0.025267476215958595, -0.03006686456501484, 0.012538529001176357, -0.06645339727401733, -0.1964588165283203, -0.0011332947760820389, 0.07082604616880417, 0.05157599598169327, 0.12900274991989136, 0.026349227875471115, -0.015425758436322212, -0.20480555295944214, 0.2462664097547531, 0.04479699581861496, 0.02164563164114952, -0.017836468294262886, 0.0763058140873909, -0.033286381512880325, -0.08875957131385803, 0.12508848309516907, -0.0028236100915819407, 0.027817972004413605, -0.04339854419231415, 0.05543474107980728, 0.078120656311512, -0.11382946372032166, 0.06357024610042572, -0.054585713893175125, 0.010843454860150814, 0.09793242812156677, -0.03460202366113663, 0.07583494484424591, -0.08385387808084488, 0.11932559311389923, -0.05206986516714096, -0.023949626833200455, 0.01585249789059162, -0.06978807598352432, -0.09024720638990402, 0.014229115098714828, 0.10461415350437164, -0.022703835740685463, -1.132983038435181e-32, -0.02421112172305584, 0.020304089412093163, -0.00014782045036554337, -0.00882461853325367, -0.03235749900341034, -0.017564738169312477, 0.1038290485739708, -0.038017742335796356, -0.06345236301422119, -0.135962575674057, -0.1264471858739853, 0.06584137678146362, -0.1300705224275589, 0.1064096987247467, 0.020893951877951622, 0.015989139676094055, 0.08847225457429886, -0.16437241435050964, -0.1428186446428299, -0.04308292269706726, 0.012037363834679127, 0.08227884024381638, -0.08499550074338913, 0.008481381461024284, 0.03805634379386902, 0.12894965708255768, -0.04720744490623474, 0.0144353611394763, 0.0855688750743866, -0.07673397660255432, -0.02971484325826168, 0.017882799729704857, -0.1940537691116333, 0.02599315531551838, -0.007899772375822067, -0.12222988158464432, -0.043534986674785614, -0.13666875660419464, -0.015608271583914757, -0.06276750564575195, 0.12281288206577301, 0.07558365166187286, -0.08551982790231705, -0.005115460138767958, 0.03417414054274559, -0.11074070632457733, 0.02426556870341301, -0.002308282535523176, 0.2302090972661972, 0.11524539440870285, 0.12760040163993835, -0.03756103664636612, -0.011031471192836761, 0.09599988162517548, -0.020158158615231514, 0.1310107409954071, 0.048502206802368164, 0.003975274972617626, -0.03818826377391815, 0.09502647817134857, 0.029401857405900955, 0.0771646648645401, -0.027731813490390778, 0.018318846821784973, 0.011218447238206863, -0.018676217645406723, 0.0188381876796484, -0.06326659023761749, -0.01341620646417141, -0.08261193335056305, -0.05836882442235947, 0.02714446187019348, -0.003194652032107115, -0.0003773435018956661, -0.05498545989394188, 0.37281620502471924, -0.10136527568101883, -0.12527509033679962, -0.08471839129924774, 0.01896636374294758, -0.02783418633043766, -0.05778227001428604, 0.0965452492237091, 0.03165571764111519, -0.03532709553837776, 0.0322306826710701, -0.12698113918304443, -0.21802839636802673, -0.07075528055429459, 0.029238231480121613, -0.018212061375379562, -0.21156683564186096, -0.028039000928401947, -0.007399618625640869, 0.10255227982997894, -1.0030802144456175e-07, 0.005483692977577448, 0.00947769545018673, 0.036298856139183044, -0.03315838426351547, 0.18526971340179443, -0.08428674936294556, 0.08258267492055893, 0.03526689484715462, 0.04408606141805649, 0.1603500247001648, 0.1288033276796341, 0.10679004341363907, -0.11792193353176117, 0.1649174839258194, -0.12807732820510864, 0.1283150315284729, -0.14372095465660095, -0.06468883901834488, -0.1183222234249115, -0.010191884823143482, 0.004668128676712513, -0.0026775049045681953, -0.0740424394607544, 0.039198145270347595, 0.08081316202878952, -0.13146793842315674, 0.051713380962610245, 0.1517311930656433, -0.015256618149578571, 0.053140074014663696, 0.039014384150505066, -0.040829725563526154, 0.01387547142803669, -0.08413257449865341, 0.05539080128073692, -0.12014366686344147, 0.06269535422325134, 0.020269079133868217, -0.04044828563928604, 0.14730817079544067, 0.015071254223585129, 0.0057320743799209595, 0.028039343655109406, -0.04019372537732124, 0.036085523664951324, -0.14534369111061096, -0.24207788705825806, 0.1299363225698471, 0.024563373997807503, -0.13333861529827118, 0.10608923435211182, -0.023699652403593063, 0.011762172915041447, 0.13403750956058502, 0.13445618748664856, -0.022453997284173965, -0.10419297218322754, 0.0029523251578211784, -0.14712470769882202, -0.0028443653136491776, 0.012648978270590305, -0.11766786873340607, 0.11124482750892639, 0.041282519698143005], "changes": {"1wk": -6.70391102378272, "1mo": -15.083798138576872}}, {"text": "Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Lags Revenue Estimates Zacks Equity Research Thu, Nov 7, 2024, 2:05 AM 3 min read In This Article: CRBU -4.20% Caribou Biosciences, Inc. (CRBU) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of $0.44. This compares to loss of $0.12 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 13.64%. A quarter ago, it was expected that this company would post a loss of $0.45 per share when it actually produced a loss of $0.42, delivering a surprise of 6.67%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Caribou Biosciences , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $2.02 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 39.99%. This compares to year-ago revenues of $23.66 million. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Caribou Biosciences shares have lost about 55.3% since the beginning of the year versus the S&P 500's gain of 21.2%. What's Next for Caribou Biosciences? While Caribou Biosciences has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Caribou Biosciences: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.45 on $3.83 million in revenues for the coming quarter and -$1.76 on $11.3 million in revenues for the current fiscal year. Story Continues Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Biomedical and Genetics is currently in the top 38% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. CervoMed Inc. (CRVO), another stock in the same industry, has yet to report results for the quarter ended September 2024. This company is expected to post quarterly loss of $0.41 per share in its upcoming report, which represents a year-over-year change of +41.4%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. CervoMed Inc.'s revenues are expected to be $1.75 million, up 14.4% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Caribou Biosciences, Inc. (CRBU) : Free Stock Analysis Report CervoMed Inc. (CRVO) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CRBU", "date": "2024-11-06T23:05:08+00:00", "sentiment": {"score": -0.8215167559683323, "confidence": 0.8547948002815247, "probabilities": {"positive": 0.03327804431319237, "negative": 0.8547948002815247, "neutral": 0.11192724108695984}}, "embedding": [-0.09320487827062607, 0.0133033012971282, -0.041604507714509964, 0.09611980617046356, 0.01674024760723114, 0.010516133159399033, -0.09261493384838104, 0.12153145670890808, 0.10210311412811279, 0.10086450725793839, -0.1241069957613945, -0.05291299149394035, -0.006051270291209221, -0.03751593455672264, -0.1939869225025177, -0.028884069994091988, -0.027168186381459236, -0.04237373173236847, -0.08754365146160126, 0.05666142702102661, -0.1311301440000534, 0.046266619116067886, 0.051790475845336914, 0.10866612941026688, 0.11686082184314728, -0.008391553536057472, -0.1471814215183258, 0.02291414700448513, -0.17988596856594086, -0.05415511131286621, 0.00956653244793415, 0.12146246433258057, 0.1066775918006897, -0.09118475764989853, 0.0024800924584269524, -0.0378057062625885, -0.027134722098708153, -0.014734518714249134, 0.078285351395607, 0.028610071167349815, -0.09442020952701569, 0.04364106059074402, -0.18010610342025757, 0.02935764193534851, -0.0768689513206482, -0.09298976510763168, 0.041687481105327606, -0.0048274090513587, 0.060100115835666656, 0.029227163642644882, -0.251534640789032, -0.17632386088371277, 0.06041797995567322, 0.04213108494877815, -0.05219928175210953, 0.1053173691034317, -0.07571923732757568, -0.066592276096344, 0.09999284148216248, 0.020807042717933655, 0.07822267711162567, -0.02747935801744461, 0.08034057915210724, 0.04319702088832855, 0.20847421884536743, -0.039993371814489365, -0.06389939785003662, 0.012515426613390446, -0.06909409165382385, 0.08104100823402405, 0.1462993323802948, -0.03132512792944908, -0.02842622809112072, -0.02851678803563118, -0.1062723696231842, 0.1140710711479187, 0.08197961747646332, 0.09918799996376038, 0.1152876615524292, -0.053070783615112305, 0.01283520832657814, -0.08205817639827728, -0.07212333381175995, -0.1323889195919037, 0.006384543143212795, 0.022871162742376328, 0.19642604887485504, 0.07909420132637024, -0.02604878693819046, 0.04932735115289688, 0.050637517124414444, -0.1252274066209793, 0.03286653012037277, -0.05566541850566864, -0.05605468153953552, 0.04059620574116707, -0.00897846557199955, -0.16314107179641724, 0.10638593137264252, -0.009323152713477612, 0.08474329113960266, 0.1767212599515915, -0.008368948474526405, -0.16207405924797058, 0.014569519087672234, -0.11757014691829681, 0.00743873231112957, 0.026735153049230576, 0.05408675968647003, 0.14253279566764832, -0.06805121898651123, 0.12049548327922821, -0.14925582706928253, 0.01236463338136673, -0.03768695518374443, 0.12207383662462234, -0.07905962318181992, 0.1385641098022461, 0.11513900756835938, 0.14055687189102173, 0.08881018310785294, 0.0917559564113617, 0.00025118421763181686, -0.11590142548084259, 0.04655114561319351, 0.016213851049542427, -0.21500127017498016, 7.455608184920883e-33, 0.09232965111732483, 0.11247769743204117, -0.03811506927013397, -0.08795593678951263, -0.05242766812443733, -0.020990900695323944, -0.07800737023353577, -0.00045894086360931396, 0.030345145612955093, -0.12239944934844971, -0.20615874230861664, 0.10516726225614548, 0.02989584021270275, -0.017897464334964752, -0.03421546146273613, -0.08495750278234482, -0.19129812717437744, -0.01967458985745907, -0.042435936629772186, -0.01128192339092493, -0.004262406378984451, -0.011337723582983017, -0.03856750577688217, 0.09304431080818176, 0.027820121496915817, 0.02953927405178547, -0.04525664076209068, 0.0778619721531868, -0.105328768491745, 0.08628806471824646, 0.011212113313376904, 0.024700889363884926, -0.019231881946325302, -0.17610615491867065, -0.03126097470521927, -0.1190786138176918, 0.00500950263813138, -0.040318313986063004, 0.0972786545753479, 0.14350372552871704, -0.025444816797971725, 0.045634038746356964, -0.13967496156692505, -0.2301495373249054, 0.017484143376350403, -0.025997577235102654, 0.11232172697782516, 0.04657670855522156, 0.011840016581118107, -0.05373454838991165, -0.0902397483587265, -0.016874805092811584, 0.026600472629070282, -0.06526877731084824, -0.054711077362298965, 0.04675283655524254, -0.06741216778755188, -0.2428562045097351, 0.02441965416073799, 0.08584330976009369, 0.12827377021312714, 0.32837510108947754, 0.13154199719429016, -0.041275352239608765, -0.1995341181755066, 0.20821934938430786, 0.0015562218613922596, 0.05399660766124725, -0.07309142500162125, 0.17715182900428772, 0.00628378801047802, -0.1308780014514923, 0.13492007553577423, -0.10516099631786346, 0.15999862551689148, -0.061887145042419434, -0.004256559535861015, -0.014268636703491211, 0.043720364570617676, 0.01668812707066536, 0.0637093260884285, -0.02356460690498352, 0.063059963285923, -0.02945079281926155, 0.0993288904428482, -0.038389578461647034, 0.03161356598138809, 0.04178028553724289, -0.0266743004322052, -0.009146886877715588, 0.03474561870098114, -0.14726951718330383, -0.044234126806259155, 0.06049502640962601, -0.036310192197561264, -7.951779207615186e-33, -0.12252511084079742, 0.042151518166065216, 0.017042331397533417, 0.03147972375154495, -0.07933363318443298, -0.029883360490202904, 0.09699416160583496, 0.05437993258237839, -0.006120728328824043, -0.09350632131099701, -0.06016801297664642, 0.1120966374874115, -0.13624170422554016, 0.054053667932748795, -0.011541296727955341, 0.062106966972351074, 0.04347463324666023, -0.1793886125087738, -0.01344289816915989, -0.08695375919342041, 0.03986315056681633, 0.15903283655643463, -0.08858554810285568, 0.08036139607429504, 0.10127726197242737, 0.13046926259994507, 0.03920233994722366, 0.13708479702472687, 0.08813073486089706, -0.09095631539821625, 0.002231951802968979, -0.03746568784117699, -0.18847446143627167, 0.09638641774654388, 0.014621693640947342, -0.021827969700098038, -0.06498938798904419, -0.12220636010169983, -0.010515810921788216, -0.029159393161535263, 0.21813064813613892, 0.06322693824768066, -0.04030773788690567, -0.015342742204666138, 0.06689640134572983, -0.05448592081665993, 0.002925034612417221, -0.01540398970246315, 0.26932865381240845, 0.12618030607700348, 0.05853793025016785, 0.02300848811864853, -0.09177926927804947, 0.14824998378753662, -0.08981698751449585, 0.06826084107160568, -0.0784260556101799, 0.06572511792182922, -0.1561812460422516, 0.12062623351812363, 0.016561012715101242, 0.11958420276641846, 0.01619628071784973, 0.06233088672161102, 0.04524626582860947, 0.05292145162820816, 0.028643492609262466, 0.021004553884267807, 0.11039502918720245, -0.1273944079875946, 0.0898539274930954, -0.04239029437303543, 0.11271297186613083, -0.184627503156662, -0.042822860181331635, 0.3855540156364441, -0.15596912801265717, -0.16020742058753967, -0.10893236100673676, 0.012479723431169987, 0.14411897957324982, -0.004806894809007645, 0.12322299182415009, 0.047866158187389374, -0.05212371051311493, 0.10654827952384949, -0.12231915444135666, -0.07695148140192032, -0.08121202141046524, 0.015470851212739944, -0.044823724776506424, -0.1600838005542755, -0.09406504034996033, 0.04372850060462952, 0.17398568987846375, -9.984854898448248e-08, 0.13716185092926025, -0.029258092865347862, 0.12786903977394104, -0.07126231491565704, 0.17113812267780304, -0.08501803129911423, -0.006170627661049366, 0.014575508423149586, 0.04348544776439667, 0.12189732491970062, 0.008652305230498314, -0.028616461902856827, -0.14795029163360596, 0.14481085538864136, -0.10252241045236588, 0.07834482938051224, -0.09712086617946625, 0.00974353402853012, -0.05940256640315056, -0.07897430658340454, -0.049027249217033386, 0.007965710014104843, 0.03642401099205017, -0.08113560080528259, 0.033592209219932556, -0.12730862200260162, -0.03670845925807953, -0.018824134021997452, -0.0754314661026001, 0.01588626019656658, 0.04352658987045288, -0.03467591851949692, 0.04024997353553772, 0.028286868706345558, -0.019965946674346924, -0.1276487112045288, 0.01680958829820156, 0.04006071016192436, -0.055063195526599884, 0.08490325510501862, 0.01843671128153801, -0.026569534093141556, 0.00898850616067648, 0.04787428677082062, -0.05945810675621033, -0.11682145297527313, -0.14831596612930298, 0.041138723492622375, 0.0191525686532259, -0.21801069378852844, 0.15369397401809692, -0.043331582099199295, -0.019113419577479362, 0.08786076307296753, 0.06872868537902832, 0.10600254684686661, -0.16713210940361023, -0.08661273866891861, -0.22823882102966309, -0.01869398169219494, 0.044738851487636566, -0.25329068303108215, 0.11480733007192612, 0.07006275653839111], "changes": {"1wk": -19.9999982660467, "1mo": -22.54545038396662}}, {"text": "Caribou Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag editorial-team@simplywallst.com (Simply Wall St) Fri, Nov 8, 2024, 2:22 PM 1 min read In This Article: CRBU -4.20% Caribou Biosciences ( NASDAQ:CRBU ) Third Quarter 2024 Results Key Financial Results Revenue: US$2.02m (down 91% from 3Q 2023). Net loss: US$34.7m (loss widened by 247% from 3Q 2023). US$0.38 loss per share (further deteriorated from US$0.12 loss in 3Q 2023). NasdaqGS:CRBU Earnings and Revenue History November 8th 2024 All figures shown in the chart above are for the trailing 12 month (TTM) period Caribou Biosciences EPS Beats Expectations, Revenues Fall Short Revenue missed analyst estimates by 35%. Earnings per share (EPS) exceeded analyst estimates by 14%. Looking ahead, revenue is forecast to grow 64% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Biotechs industry in the US. Performance of the American Biotechs industry. The company's shares are up 42% from a week ago. Risk Analysis Before we wrap up, we've discovered 4 warning signs for Caribou Biosciences (1 makes us a bit uncomfortable!) that you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CRBU", "date": "2024-11-08T11:22:17+00:00", "sentiment": {"score": -0.2442789301276207, "confidence": 0.3115956783294678, "probabilities": {"positive": 0.06731674820184708, "negative": 0.3115956783294678, "neutral": 0.6210876107215881}}, "embedding": [-0.004470105282962322, -0.0374564602971077, -0.0958852544426918, 0.0787145346403122, 0.05889859050512314, 0.053776100277900696, -0.06729286164045334, 0.14606940746307373, -0.014637001790106297, 0.016377069056034088, -0.10351315140724182, -0.057560671120882034, -0.01641012169420719, -0.015252899378538132, -0.1574956178665161, -0.014063021168112755, -0.04044893756508827, -0.09187611937522888, -0.033652059733867645, 0.09496085345745087, -0.10905073583126068, 0.06633128970861435, -0.05208515748381615, 0.06255805492401123, 0.06212357431650162, -0.05199240520596504, -0.09437820315361023, 0.03502175211906433, -0.16934387385845184, -0.08561010658740997, -0.027010519057512283, 0.08598773181438446, 0.11049292981624603, -0.09608082473278046, 0.032378900796175, 0.055891796946525574, -0.07411235570907593, -0.006411104463040829, 0.06782887876033783, -0.010980946011841297, -0.008509617298841476, -0.020093098282814026, -0.09343118220567703, 0.03880706802010536, -0.03854118287563324, -0.056153688579797745, 5.0915612519020215e-05, 0.03839012607932091, 0.06813404709100723, -0.01618257351219654, -0.2070923149585724, -0.08023867756128311, 0.0117479944601655, 0.01941313035786152, 0.03863108903169632, 0.019227292388677597, -0.08331842720508575, -0.07464810460805893, 0.05904388800263405, -0.1068771481513977, 0.050964292138814926, 0.0007530568400397897, 0.05542774870991707, 0.019417474046349525, 0.14673247933387756, -0.019216038286685944, -0.08401046693325043, 0.13333365321159363, -0.03774246200919151, 0.06837663054466248, 0.07080263644456863, -0.06677990406751633, -0.10976675152778625, 0.05047781392931938, -0.047654420137405396, 0.21074968576431274, 0.09752154350280762, 0.10558207333087921, 0.1304071545600891, -0.11181069165468216, 0.015109112486243248, -0.006685822736471891, -0.07268054783344269, -0.14380402863025665, -0.08066507428884506, -0.06475722044706345, 0.1543828547000885, 0.023691052570939064, 0.025189606472849846, 0.03584660589694977, 0.22377702593803406, -0.060860518366098404, 0.020441927015781403, -0.006665612570941448, 0.03429899364709854, -0.06743701547384262, -0.07141335308551788, -0.14716728031635284, 0.013661598786711693, 0.008182091638445854, 0.09554007649421692, 0.09972069412469864, -0.0619320347905159, -0.060119885951280594, -0.11786875873804092, -0.039230458438396454, 0.0018672568257898092, 0.08964414149522781, 0.012709995731711388, 0.11232802271842957, -0.09045315533876419, 0.1555800586938858, -0.1592387855052948, -0.0699019655585289, 0.004063964355736971, 0.06838735938072205, -0.05694570392370224, -0.04344865307211876, 0.21628835797309875, 0.06374038755893707, 0.06177818775177002, 0.11656918376684189, -0.02821469120681286, -0.07467629015445709, 0.046428319066762924, -0.04387636110186577, -0.16506890952587128, 1.312293681393582e-32, 0.055378809571266174, 0.09939070045948029, -0.002285698428750038, -0.13035869598388672, -0.013347345404326916, 0.05485650897026062, -0.08968058973550797, -0.025548765435814857, 0.03536593168973923, -0.05056681111454964, -0.2118673175573349, 0.15614022314548492, 0.08157102018594742, -0.040404219180345535, -0.04557544365525246, -0.05785883218050003, -0.026607796549797058, -0.028259610757231712, -0.051928840577602386, -0.007846571505069733, 0.0008340816712006927, -0.0190749391913414, -0.025311224162578583, 0.12191861122846603, 0.0866495817899704, -0.06929056346416473, -0.0032540850806981325, 0.0007251073839142919, -0.07014773786067963, 0.07751289010047913, -0.032816410064697266, 0.028093401342630386, -0.09137453138828278, -0.10549131780862808, -0.007557511795312166, -0.08625093847513199, -0.12549616396427155, -0.0538453608751297, 0.05637481436133385, 0.08749878406524658, -0.023038350045681, 0.03990567475557327, -0.055301107466220856, -0.10970918834209442, 0.07982181012630463, 0.07675543427467346, 0.04817874729633331, 0.0242814552038908, 0.011473139747977257, -0.02669638767838478, -0.12335827946662903, 0.010159644298255444, -0.051969461143016815, -0.05964276194572449, -0.09042055904865265, 0.04293019697070122, -0.016612283885478973, -0.16528111696243286, 0.04056147485971451, 0.019000357016921043, 0.03701836243271828, 0.24079196155071259, 0.08721509575843811, -0.10598873347043991, -0.20195196568965912, 0.1150645837187767, -0.12222331762313843, 0.05525105819106102, -0.034573912620544434, 0.06443769484758377, -0.06734124571084976, -0.06508980691432953, 0.2597961127758026, -0.036089129745960236, 0.06511218100786209, -0.01850522868335247, -0.0360499769449234, 0.054881781339645386, -0.03081856295466423, -0.0015804392751306295, -0.021630290895700455, 0.06992518156766891, 0.04828735440969467, -0.07289104908704758, 0.00020979235705453902, -0.01923319324851036, 0.09832675755023956, 0.022757209837436676, -0.06856881827116013, 0.11641814559698105, -0.03701460361480713, -0.022715995088219643, -0.009189561940729618, 0.1838323473930359, -0.08708510547876358, -1.382596178159623e-32, -0.08579906821250916, -0.00728604756295681, 0.10095672309398651, -0.025750454515218735, -0.05411992594599724, 0.008293891325592995, 0.07814324647188187, 0.09325363487005234, 0.00753543758764863, -0.1749143898487091, -0.005358608905225992, 0.11458057910203934, -0.06892241537570953, 0.006479044444859028, 0.0014195690164342523, 0.06693745404481888, 0.0759989321231842, -0.1246546283364296, -0.09960026293992996, -0.041861243546009064, -0.02431056834757328, 0.1851004958152771, -0.20000360906124115, 0.09685081988573074, 0.061868298798799515, 0.13881132006645203, 0.10617753118276596, 0.061655208468437195, 0.04966683313250542, -0.031077682971954346, -0.0684526115655899, 0.0894421637058258, -0.23182453215122223, 0.1548045426607132, -0.06100115180015564, 0.006545370910316706, 0.07409930229187012, -0.15669327974319458, -0.012981018051505089, -0.07002923637628555, 0.22220638394355774, 0.11757320165634155, -0.062152519822120667, -0.0052847410552203655, 0.039113447070121765, -0.045983441174030304, 0.06915371865034103, -0.03746684268116951, 0.10949534922838211, 0.16724634170532227, 0.09118048846721649, 0.027612267062067986, -0.029403194785118103, 0.06885305792093277, -0.08376125991344452, 0.003702497575432062, 0.019627662375569344, 0.0034907518420368433, -0.12376312911510468, 0.0820351094007492, 0.05030261352658272, 0.12989258766174316, -0.039665453135967255, -0.09399861842393875, 0.08312670141458511, -0.009489658288657665, 0.050881896167993546, -0.04097602516412735, 0.14082419872283936, -0.06275497376918793, 0.07067426294088364, -0.0027705987449735403, 0.04418542981147766, -0.14425496757030487, -0.005579324439167976, 0.3041427433490753, -0.11048233509063721, -0.13486285507678986, -0.13580378890037537, 0.11377175897359848, 0.06211454048752785, -0.010201076045632362, 0.12997552752494812, 0.06069382652640343, 0.0237992275506258, 0.06880278885364532, -0.10053186118602753, -0.08305869996547699, -0.032493531703948975, -0.010140370577573776, -0.1305183619260788, -0.18084262311458588, -0.06467897444963455, 0.049892738461494446, 0.11614037305116653, -9.975475023793479e-08, 0.12713277339935303, -0.123363196849823, 0.11616357415914536, -0.06454510241746902, 0.11862224340438843, -0.08502928167581558, -0.03259117156267166, 0.004659650847315788, -0.017188942059874535, 0.11214043945074081, 0.03362440690398216, 0.02016204595565796, -0.17264512181282043, 0.04770345240831375, -0.09688717871904373, 0.0630829930305481, -0.13362149894237518, 0.016613321378827095, -0.09700489789247513, -0.09815534949302673, -0.012443837709724903, 0.052351437509059906, -0.10164939612150192, -0.009768168441951275, 0.11068084090948105, -0.15652069449424744, 0.013184419833123684, 0.08684729039669037, -0.03445710241794586, -0.03153598681092262, 0.026969587430357933, -0.06886898726224899, 0.05496598035097122, -0.045280665159225464, 0.016981640830636024, -0.09249278157949448, 0.17761380970478058, -0.007385783828794956, -0.02768070250749588, 0.1761731058359146, 0.04556948319077492, -0.03972908481955528, 0.05080655589699745, -0.00518310209736228, -0.08093530684709549, -0.10683616995811462, -0.12320661544799805, 0.04586965590715408, 0.047924816608428955, -0.14589427411556244, 0.14836463332176208, -0.05065857246518135, 0.014830381609499454, 0.14603455364704132, 0.07608000189065933, 0.049606043845415115, -0.11589527130126953, -0.0635603740811348, -0.0991135761141777, 0.013365969061851501, 0.04152219370007515, -0.24991916120052338, 0.07615257054567337, 0.09705231338739395], "changes": {"1wk": -22.014930518333543, "1mo": -20.52238576925797}}, {"text": "Caribou Biosciences, Inc. (NASDAQ:CRBU) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year editorial-team@simplywallst.com (Simply Wall St) Sun, Nov 10, 2024, 3:52 PM 3 min read In This Article: CRBU -4.20% Shareholders will be ecstatic, with their stake up 21% over the past week following Caribou Biosciences, Inc. 's ( NASDAQ:CRBU ) latest quarterly results. Statutory losses were much smaller than expected, at just US$0.38 per share, even though revenues of US$2.0m missed analyst expectations by a remarkable 35%. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year. See our latest analysis for Caribou Biosciences NasdaqGS:CRBU Earnings and Revenue Growth November 10th 2024 Taking into account the latest results, the most recent consensus for Caribou Biosciences from seven analysts is for revenues of US$12.3m in 2025. If met, it would imply a reasonable 7.2% increase on its revenue over the past 12 months. Losses are expected to increase substantially, hitting US$1.88 per share. Yet prior to the latest earnings, the analysts had been forecasting revenues of US$12.8m and losses of US$1.95 per share in 2025. It looks like there's been a modest increase in sentiment in the recent updates, with the analysts becoming a bit more optimistic in their predictions for losses per share, even though the revenue numbers fell somewhat. The consensus price target was broadly unchanged at US$15.50, implying that the business is performing roughly in line with expectations, despite adjustments to both revenue and earnings estimates. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. The most optimistic Caribou Biosciences analyst has a price target of US$30.00 per share, while the most pessimistic values it at US$3.00. We would probably assign less value to the analyst forecasts in this situation, because such a wide range of estimates could imply that the future of this business is difficult to value accurately. With this in mind, we wouldn't rely too heavily the consensus price target, as it is just an average and analysts clearly have some deeply divergent views on the business. Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. We would highlight that Caribou Biosciences' revenue growth is expected to slow, with the forecast 5.7% annualised growth rate until the end of 2025 being well below the historical 33% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 21% per year. Factoring in the forecast slowdown in growth, it seems obvious that Caribou Biosciences is also expected to grow slower than other industry participants. Story Continues The Bottom Line The most important thing to take away is that the analysts reconfirmed their loss per share estimates for next year. On the negative side, they also downgraded their revenue estimates, and forecasts imply they will perform worse than the wider industry. Even so, long term profitability is more important for the value creation process. The consensus price target held steady at US$15.50, with the latest estimates not enough to have an impact on their price targets. Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. We have estimates - from multiple Caribou Biosciences analysts - going out to 2026, and you can see them free on our platform here. Plus, you should also learn about the 4 warning signs we've spotted with Caribou Biosciences (including 1 which is concerning) . Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. View Comments Terms and Privacy Policy Privacy Dashboard Recommended Stories", "symbol": "CRBU", "date": "2024-11-10T12:52:26+00:00", "sentiment": {"score": 0.08280676603317261, "confidence": 0.49137404561042786, "probabilities": {"positive": 0.49137404561042786, "negative": 0.40856727957725525, "neutral": 0.10005871206521988}}, "embedding": [-0.040277428925037384, -0.0434800460934639, -0.017977822571992874, 0.07148630917072296, 0.03368033841252327, 0.03155992925167084, -0.08916128426790237, 0.10507193207740784, 0.05480291694402695, 0.09722188860177994, -0.1949363797903061, -0.028412144631147385, -0.021873462945222855, -0.01321638748049736, -0.1762235015630722, -0.005268082022666931, -0.038568876683712006, -0.10675933212041855, -0.022028401494026184, 0.0689481645822525, -0.17225892841815948, 0.06399424374103546, -0.03924288600683212, 0.07143670320510864, 0.1001371294260025, -0.028419911861419678, -0.126809760928154, -0.03226577118039131, -0.16094505786895752, -0.007992771454155445, -0.029436597600579262, 0.069427490234375, 0.10723485797643661, -0.05685386061668396, -0.034960415214300156, -0.06555479019880295, -0.04104851931333542, -0.012588918209075928, 0.07395164668560028, 0.05971807986497879, -0.03283238410949707, 0.027269475162029266, -0.1361512839794159, 0.05336897820234299, -0.06016820669174194, -0.0681355819106102, 0.05873309075832367, 0.012688263319432735, 0.01505078561604023, 0.030882643535733223, -0.26870325207710266, -0.15001754462718964, 0.04981866106390953, -0.059430044144392014, 0.018361050635576248, 0.08613768965005875, -0.09219592809677124, -0.0703628808259964, 0.09395382553339005, -0.011169428937137127, -0.034667301923036575, 0.014037278480827808, 0.07080823183059692, 0.04460727423429489, 0.24546003341674805, -0.04072178900241852, -0.05652105435729027, 0.042306795716285706, -0.07571781426668167, 0.07802485674619675, 0.06687098741531372, -0.06204597279429436, 0.003779021091759205, -0.14185777306556702, -0.05679928511381149, 0.17131754755973816, 0.07865003496408463, 0.09409229457378387, 0.12763403356075287, -0.10021372139453888, 0.009595748968422413, -0.07529798895120621, -0.11520527303218842, -0.17688579857349396, -0.04222641885280609, -0.030682716518640518, 0.18465833365917206, -0.0037618549540638924, -0.017782535403966904, 0.026381205767393112, 0.15709717571735382, -0.09628428518772125, 0.02588335983455181, 0.008559592068195343, -0.04007588326931, 0.06915859878063202, -0.06421846896409988, -0.1516796201467514, 0.07490455359220505, 0.010357643477618694, 0.089334636926651, 0.1850983202457428, 0.02709319442510605, -0.12586504220962524, -0.09292033314704895, -0.12133494764566422, 0.025971639901399612, 0.016161222010850906, -0.0015500662848353386, 0.11452653259038925, -0.0622602142393589, 0.15771512687206268, -0.13556069135665894, -0.04767780005931854, -0.023016367107629776, 0.06692447513341904, -0.03782891854643822, 0.05522590130567551, 0.1150849461555481, 0.05675099790096283, 0.056347087025642395, 0.0850684717297554, 0.04155438765883446, -0.05494026467204094, 0.09768165647983551, 0.021746475249528885, -0.23533734679222107, 1.2433634273453324e-32, 0.06383194774389267, 0.06032927334308624, 0.020768525078892708, -0.13202878832817078, -0.0803459882736206, -0.008494872599840164, -0.08591820299625397, 0.0006183732766658068, 0.042321283370256424, -0.11047914624214172, -0.17064426839351654, 0.15669074654579163, 0.040953777730464935, 0.022546328604221344, -0.023531721904873848, -0.09260281175374985, -0.11061020940542221, -0.010362446308135986, -0.09228448569774628, 0.010820220224559307, -0.020650791004300117, 0.036908041685819626, -0.05737953633069992, 0.05878252536058426, 0.05668129771947861, -0.02663036622107029, 0.0038764607161283493, 0.07061740756034851, -0.09165048599243164, 0.07587452232837677, -0.006403793580830097, -0.00044813938438892365, -0.08270758390426636, -0.09497997909784317, -0.013665307313203812, -0.12281976640224457, -0.06609803438186646, -0.00376712204888463, 0.06859077513217926, 0.08498597145080566, 0.019962966442108154, 0.014652152545750141, -0.06468657404184341, -0.1709994375705719, 0.05380665883421898, 0.008490834385156631, 0.035291142761707306, 0.026978490874171257, -0.03140602260828018, -0.09151341021060944, -0.04457823187112808, -0.05692311376333237, -0.010959947481751442, -0.03576900437474251, 0.0007271310314536095, 0.0625954121351242, -0.06312647461891174, -0.21204687654972076, 0.07249163836240768, 0.03125355765223503, 0.05417635664343834, 0.23743444681167603, 0.10076307505369186, -0.08196024596691132, -0.22103232145309448, 0.2642083168029785, -0.007173367775976658, 0.09206320345401764, -0.007699920330196619, 0.13957759737968445, 0.039006851613521576, -0.07635903358459473, 0.12192287296056747, -0.0428621843457222, 0.11359469592571259, -0.026076540350914, -0.022314947098493576, -0.008829450234770775, 0.04345369711518288, 0.0584016852080822, 0.026389867067337036, 0.029794327914714813, 0.08019199967384338, -0.04026882350444794, 0.11042163521051407, -0.07178613543510437, 0.046410202980041504, 0.06361991912126541, -0.062454089522361755, 0.0322284922003746, 0.030817527323961258, -0.06355036795139313, -0.040625326335430145, 0.10556470602750778, -0.02099432237446308, -1.3023182893957103e-32, -0.09918688237667084, 0.01620687171816826, 0.009197132661938667, 0.015036731958389282, -0.08944565057754517, -0.08845631778240204, 0.09143812954425812, 0.04368361085653305, 0.017904534935951233, -0.12007363140583038, -0.032511450350284576, 0.09349475800991058, -0.06753283739089966, 0.053110770881175995, -0.022331031039357185, 0.0041702440939843655, 0.10756253451108932, -0.1720501184463501, -0.049097321927547455, -0.09497524052858353, -0.005104651674628258, 0.12103468179702759, -0.12982138991355896, 0.04086527228355408, 0.0916399210691452, 0.07719799876213074, 0.09073655307292938, 0.06819157302379608, 0.037259913980960846, -0.09242650121450424, -0.08963221311569214, -0.021949516609311104, -0.19242103397846222, 0.1087898463010788, 0.009880196303129196, 0.030680948868393898, -0.030695021152496338, -0.15318550169467926, -0.06545393168926239, -0.02836151048541069, 0.1530437469482422, 0.04971335455775261, -0.04834920912981033, -0.040306996554136276, 0.0785612165927887, 0.002783876843750477, 0.04059211164712906, 0.05082911252975464, 0.1746612936258316, 0.1604316234588623, 0.07579970359802246, 0.023632705211639404, -0.045154985040426254, 0.05931756645441055, -0.06918804347515106, 0.032592542469501495, -0.011081688106060028, 0.02774246409535408, -0.05431033670902252, 0.11604008078575134, 0.017431186512112617, 0.10572228580713272, 0.04302559792995453, -0.07055060565471649, -0.008312538266181946, 0.030330799520015717, 0.04107031971216202, -0.018316973000764847, 0.11911888420581818, -0.10873529314994812, 0.07039889693260193, -0.0694008618593216, 0.012181682512164116, -0.08175285160541534, -0.05273567512631416, 0.31343841552734375, -0.09500102698802948, -0.12404826283454895, -0.04650980234146118, 0.05073483660817146, 0.06844647973775864, -0.0035349715035408735, 0.13743245601654053, 0.08085528016090393, 0.013837363570928574, 0.026574131101369858, -0.09363505989313126, -0.10754883289337158, -0.0651327446103096, 0.04872442036867142, -0.11919191479682922, -0.17499524354934692, -0.08803080022335052, 0.06133675575256348, 0.12950876355171204, -1.0036072950470043e-07, 0.07769961655139923, -0.007256818935275078, 0.10218451172113419, -0.030922964215278625, 0.15488466620445251, -0.08411387354135513, 0.011328230611979961, -0.009965766221284866, 0.022289954125881195, 0.15633288025856018, 0.12228795886039734, -0.023297911509871483, -0.12361820042133331, 0.15710218250751495, -0.08881710469722748, 0.14068417251110077, -0.09039019048213959, -0.06457633525133133, -0.0661388412117958, -0.08873510360717773, -0.007300164084881544, 0.04002545401453972, -0.0015461007133126259, -0.012690446339547634, 0.09922999143600464, -0.14981165528297424, -0.09664073586463928, 0.06427009403705597, -0.12187904864549637, 0.009198958054184914, 0.030855245888233185, -0.009643424302339554, 0.03201048821210861, -0.011821474879980087, -0.010867920704185963, -0.06453890353441238, 0.024363774806261063, 0.08245010673999786, 0.013378618285059929, 0.09388048946857452, -0.003437565639615059, -0.04657341539859772, 0.02092128060758114, 0.0022676093503832817, -0.07772888243198395, -0.12234736979007721, -0.14251144230365753, 0.06677140295505524, 0.0179416723549366, -0.15525329113006592, 0.14226463437080383, -0.04175810515880585, -0.011697540059685707, 0.11930831521749496, 0.16038191318511963, 0.03186245635151863, -0.13481374084949493, -0.11048722267150879, -0.16225194931030273, 0.02023267187178135, 0.025591721758246422, -0.21721148490905762, 0.08019733428955078, 0.08878833055496216], "changes": {"1wk": -28.673833808404435, "1mo": -23.29748623068596}}]